Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2006 May 24;79(1):54–61. doi: 10.1086/504926

Comprehensive Association Testing of Common Mitochondrial DNA Variation in Metabolic Disease

Richa Saxena 1, Paul I W de Bakker 1, Karyn Singer 1, Vamsi Mootha 1, Noël Burtt 1, Joel N Hirschhorn 1, Daniel Gaudet 1, Bo Isomaa 1, Mark J Daly 1, Leif Groop 1, Kristin G Ardlie 1, David Altshuler 1
PMCID: PMC1474138  PMID: 16773565

Abstract

Many lines of evidence implicate mitochondria in phenotypic variation: (a) rare mutations in mitochondrial proteins cause metabolic, neurological, and muscular disorders; (b) alterations in oxidative phosphorylation are characteristic of type 2 diabetes, Parkinson disease, Huntington disease, and other diseases; and (c) common missense variants in the mitochondrial genome (mtDNA) have been implicated as having been subject to natural selection for adaptation to cold climates and contributing to “energy deficiency” diseases today. To test the hypothesis that common mtDNA variation influences human physiology and disease, we identified all 144 variants with frequency >1% in Europeans from >900 publicly available European mtDNA sequences and selected 64 tagging single-nucleotide polymorphisms that efficiently capture all common variation (except the hypervariable D-loop). Next, we evaluated the complete set of common mtDNA variants for association with type 2 diabetes in a sample of 3,304 diabetics and 3,304 matched nondiabetic individuals. Association of mtDNA variants with other metabolic traits (body mass index, measures of insulin secretion and action, blood pressure, and cholesterol) was also tested in subsets of this sample. We did not find a significant association of common mtDNA variants with these metabolic phenotypes. Moreover, we failed to identify any physiological effect of alleles that were previously proposed to have been adaptive for energy metabolism in human evolution. More generally, this comprehensive association-testing framework can readily be applied to other diseases for which mitochondrial dysfunction has been implicated.


Mitochondria play a central role in energy metabolism, are composed of >700 known proteins,1 and are essential for generating ATP and for regulating apoptosis.2 The human mitochondrial oxidative phosphorylation (OXPHOS) machinery, which synthesizes most intracellular ATP, consists of five complexes with 85 known protein subunits. Thirteen OXPHOS subunits, 2 rRNA genes, and 22 tRNA genes are encoded by the 16.6-kb mitochondrial genome (mtDNA).

Rare mutations in both nuclear-encoded OXPHOS genes and in mtDNA result in disease syndromes with neurological, muscular, or metabolic manifestations, proving that defects in mitochondrial OXPHOS can play a causal role in human disease. Mutations in nuclear-encoded components of OXPHOS complexes have been identified in many early-onset diseases, such as Leigh syndrome (MIM 256000) and cardioencephalomyopathy (MIM 604377).2,3 Nuclear genes that encode OXPHOS assembly factors, influence mtDNA maintenance or translation, modify mitochondrial tRNA, or encode biosynthetic enzymes may be mutated in rare mitochondrial diseases.4,5 In addition, >250 mtDNA point mutations and deletions have been linked to human disease, and several of these include glucose defects or diabetes mellitus as component phenotypes—for example, mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS [MIM 540000]), Kearns-Sayre syndrome (KSS [MIM 530000]), and maternally inherited diabetes and deafness syndrome (MIDD [MIM 520000]).6,7 A mutation in the mitochondrial Leu tRNA gene (A3243G) causes MIDD,8 and a novel substitution in a highly conserved region of the mitochondrial Ile tRNA gene (T4291C) causes hypertension, hypercholesterolemia, and hypomagnesemia (MIM 500005),9 suggesting that mutations in mtDNA can cause diabetes and other metabolic defects.

Alterations in the function of OXPHOS have been recognized consistently in type 2 diabetes (MIM 125853). Reduced activity of OXPHOS enzymes and fewer, smaller mitochondria are seen by transmission electron microscopy in skeletal muscle from diabetics compared with nondiabetics.1012 From global gene-expression–profiling studies, we and others identified a subset of OXPHOS genes that are co-coordinately downregulated in muscles from individuals with type 2 diabetes compared with healthy control individuals.13,14 In addition, functional in vivo spectroscopy studies demonstrate that OXPHOS activity and rates of ATP synthesis are lower in the insulin-resistant offspring of diabetic individuals and in elderly insulin-resistant people.1517

Population genetics analysis has suggested a functional role for common variants in mtDNA. On the basis of differential conservation of missense variants in different mtDNA lineages, it was argued that positive selection influenced common mtDNA variation. Moreover, it was hypothesized that mtDNA SNPs favorable for selective adaptation to cold Northern climates during human evolution predispose to energy metabolism diseases today.2,18,19

These many lines of evidence suggest a “mitochondrial” hypothesis of disease. Specifically, inherited defects in mitochondria may play a causal role in type 2 diabetes20,21 and neurodegenerative diseases, such as Alzheimer (MIM 104300), Parkinson (MIM 168600), and Huntington (MIM 143100) diseases.22,23 Population genetics analysis specifically suggests that common mtDNA variants may be functional and relevant to disease. However, no comprehensive test, even of common variation in mtDNA, has yet been performed. Several previous reports did not consistently reproduce associations of common mtDNA variants with diabetes or metabolic traits.2429 However, these studies tested only a subset of mtDNA variation in relatively modestly sized samples of <2,000 individuals.

The goal of the present study was to perform a comprehensive test of the hypothesis that mtDNA variants influence type 2 diabetes and metabolic traits. Specifically, we sought to (1) inventory all SNPs with frequency >1% in Europeans, (2) select tagging SNPs (tSNPs) to capture this variation efficiently, (3) test all common variants and haplogroups for association with type 2 diabetes and a range of metabolic phenotypes (although sample sizes for some traits were limited), and (4) assess studywide significance of our findings by permutation testing.

Material and Methods

Alignment of Sequences

We aligned all human mtDNA coding-region sequences from GenBank (719 sequences) and 536 sequences from Mitokor30 and identified 3,240 variant sites. We excluded ∼0.8 kb of the hypervariable mtDNA D-loop promoter region from the study, since this region is best addressed by direct resequencing in case-control samples because of its high mutation rate.

Subjects and Samples

The sample consisted of 6,608 white subjects from Scandinavia (Sweden and Botnia, hereafter referred to as the “Swedish” and “Scandinavian” samples, respectively), Canada, Poland, and the United States; metabolic phenotype information was available for a subset of the subjects (table 1).31,32 The Scandinavian and Canadian diabetic case-control samples were matched for sex, age, region, and BMI (calculated as weight in kilograms divided by the square of height in meters), whereas the Polish and U.S. case-control samples were matched for sex, age, and geographical region but not tightly for BMI. BMI, blood pressure, and cholesterol values were available for diabetic and nondiabetic subjects from all five populations, and insulinogenic index and homeostasis model assessment of insulin resistance (HOMA-IR) values were obtained for nondiabetic Scandinavian and Swedish subjects (from a 2-h oral glucose tolerance test [OGTT]). The study of human subjects was approved by the institutional review boards at parent institutions for all samples and at the Broad Institute for Harvard and MIT. Genomic DNA was extracted from blood samples and lymphoblastoid cell lines.

Table 1. .

Clinical Characteristics of the Diabetes Case-Control Study Samples and Quantitative Metabolic Traits in Subjects Used to Study Genotype-Phenotype Correlations[Note]

Sample or Traita n No. of Males; Females Age
(years)
BMI Fasting
Plasma
Glucose
(mmol/liter)
HbA1cb
(%)
Plasma
Glucose
by 2-h OGTT
(mmol/liter)
Trait Value
Case-control sample:
 Scandinavian:
  DM/severe IGT 459 247; 212 60.9 ± 10.2 28.2 ± 4.6 9.8 ± 3.4 15.0 ± 5.3
  NGT 459 247; 212 59.6 ± 10.4 26.3 ± 3.6 6.2 ± 1.8 6.8 ± 2.8
 Swedish:
  DM/severe IGT 505 264; 241 66.3 ± 11.8 27.6 ± 4.1 9.8 ± 3.4 6.5 ± 1.5
  NGT 505 264; 241 66.6 ± 11.6 27.7 ± 4.1 6.2 ± 1.8 ND ND
 Canadian:
  DM 123 67; 56 53.5 ± 7.9 29.2 ± 4.4 6.4 ± 1.8 12.8 ± 2.1
  NGT 123 67; 56 52.1 ± 7.9 28.6 ± 4.1 5.1 ± 0.6 6.1 ± 1.1
 U.S.c:
  DM 1,214 641; 573 62.6 ± 11.0 33.0 ± 6.9 9.8 ± 3.0 8.0 ± 3.1
  NGT 1,214 641; 573 60.9 ± 9.7 27.4 ± 5.2 5.1 ± 0.9 ND ND
 Polishc:
  DM 1,003 420; 583 61.8 ± 9.6 29.6 ± 4.8 8.9 ± 4.0 7.9 ± 1.3
  NGT 1,003 420; 583 58.7 ± 7.2 26.1 ± 3.6 4.8 ± 1.2 ND ND
Trait:
 Ins index 342 181; 161 58.5 ± 10.1 26.2 ± 3.6 22.6 ± 31.3
 HOMA-IR 399 210; 189 59.2 ± 10.3 26.3 ± 3.7 2.1 ± 1.3
 Cholesterol 1,274 682; 592 62.5 ± 11.1 27.4 ± 4.2 6.0 ± 1.2 mmol
 Systolic BP 2,047 1,090; 957 62.2 ± 11.7 27.7 ± 4.2 144 ± 22 mm Hg
 Diastolic BP 2,047 1,090; 957 62.2 ± 11.7 27.7 ± 4.2 83 ± 10 mm Hg

Note.— Data are means ± SD. ND = not determined.

a

BP = blood pressure; DM = diabetes mellitus, type 2; IGT = impaired glucose tolerance; Ins = insulinogenic; NGT = normal glucose tolerance.

b

HbA1c = hemoglobin A1c.

c

Sample from Genomics Collaborative Inc.

Genotyping

Genotyping was performed by primer extension of multiplex products with detection by matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy with use of a Sequenom platform.33 Genotyping for the 64 tSNPs was >98%; maternal inheritance was confirmed for tSNPs by genotyping in 117 CEPH trios (not shown). Two SNPs (mt14470 and mt15884) were triallelic in this population. Duplicate genotypes were obtained for ∼20% of the sample with 22 SNPs and were highly concordant (0.1% discordant genotypes of 29,462 duplicate comparisons). For 69 samples (1.1% of samples genotyped), we observed spectral peaks for both the major and minor allele for 1–3 SNPs per sample. In total, 21 SNPs had heterozygous calls in at least one individual. These observations are consistent with either DNA contamination or heteroplasmy (more than one mtDNA haplotype arising from somatic/maternal germ line mutations or from the paternal mtDNA contribution). Signals for both alleles were seen in individuals from all populations, and no significant difference in the number of cases and controls with such genotypes was observed. For analysis, these genotypes were treated as missing data.

Results

Previous studies have tested subsets of mtDNA variants (from 10–32 sites) for association with a variety of traits,2427,3449 typically focusing on the nine canonical haplogroups.50 We began by cataloging all common sites (frequency >1%) in 15,770 bp of mtDNA (excluding the coding region) and by evaluating how well the complete inventory is captured by these canonical haplogroups in mtDNAs of European origin. Alignment of 928 European coding-region mtDNA sequences (>15,770 bp) identified 2,349 variable sites; 144 sites had a frequency >1% in European individuals (1 site per 110 bp), including 37 nonsynonymous variants, 81 synonymous variants, 25 rRNA/tRNA variants, and 1 noncoding variant (table 2). Fifty variants with frequency >5% were identified. The common variants (frequency >1%) explained 72% of the “heterozygosity” in the European population; this is notably less than in the nuclear genome, where ∼90% of heterozygosity is due to common variants.5153

Table 2. .

Common European mtDNA Variants with Frequency >1%, by Gene of Origin

Genea OXPHOS Complex Putatively Functional Missense
Mutations
Synonymous
Mutations
Total
ND1 1 5 5 10
ND2 1 6 11 17
ND3 1 2 1 3
ND4L 1 1 1
ND4 1 15 15
ND5 1 6 15 21
ND6 1 1 5 6
Cyt B 3 9 5 14
COX1 4 10 10
COXII 4 4 4
COXIII 4 3 4 7
ATP6 5 5 5 10
12SrRNA 6 6
16SrRNA 7 7
tRNA Gln 1 1
tRNA Ser 1 1
tRNA Gly 2 2
tRNA Arg 1 1
tRNA Ser2 1 1
tRNA Leu2 1 1
tRNA Glu 1 1
tRNA Thr 4 4
Noncoding 1
 Total 25 37 81 144
a

One ATP6 missense variant is also a synonymous ATP8 variant; no common variants in 14 tRNA genes.

Evaluation of previous sets of tSNPs used for disease association studies revealed that ∼30% of variants (frequency ⩾1%) are captured with r2⩾0.8 (table 3). Recently,27 more-complete coverage of mtDNA variation was reported using 32 mtDNA SNPs; still, these SNPs capture less than half of the sites (42%) at r2⩾0.8. Thus, previous studies might have missed a true association simply because not all variants were captured by the tSNPs used.

Table 3. .

Estimated Fraction of mtDNA Coding-Region Variation Captured by Previous Association Studies Compared with the Present Study

Percentage of SNPs Captured
Study tSNPs Testsa r2⩾.5 r2⩾.8
Van der Walt et al.47 9b 9 HGs + 9 SNPs 35 30
Huerta et al.49 12b 9 HGs + 12 SNPs 33 26
Niemi et al.42 8 9 HGs 34 26
Mohlke et al.27 32c 9 HGs + 32 SNPs 54 42
Present study 64 All variants with frequency >1% 100 100
a

HGs = haplogroups.

b

One D-loop–region SNP was used to specify haplogroup I; this SNP was excluded from our evaluation of the coverage of coding-region mtDNA SNPs.

c

Ten SNPs chosen by Mohlke et al.27 (in Finns) were observed at a frequency <1% in the 928 European sequences of the reference panel.

We selected a set of 64 SNPs that capture each of the 144 sites as well as the nine haplogroups with r2⩾0.8, using Tagger54; tSNPs and predictive tests are listed in table 4. Details on the assay conditions are available online (Broad Institute Tagger: SNPs in human mtDNA Web site).

Table 4. .

tSNPs and Tests Used to Predict All Coding-Region Variants with Frequency >1% in European mtDNA

SNP or Haplogroup Position (rCRSa) Alleles (Major/Minor) Rarer Allele Frequency (Reference Panel) Captured by Test (tSNP or Haplotype) Test Allele(s) Test Allele Frequency (Reference Panel) r2 for Test vs. Predicted Allele SNP Type
SNP:
 mt709 709 G/A .20 mt709 tSNP
 mt750 750 G/A .01 mt750 tSNP
 mt930 930 G/A .05 mt930 tSNP
 mt1189 1189 T/C .07 mt1189 tSNP
 mt1243 1243 T/C .05 mt11674 T .05 1
 mt1438 1438 G/A .03 mt4769 A .02 .872
 mt1719 1719 G/A .06 mt709, mt12007, mt12705 G, G, T .05 .836
 mt1811 1811 A/G .13 mt3348, mt9477, mt12372 A, G, A .13 .944
 mt1888 1888 G/A .11 mt11812, mt12633 A, C .89 .978
 mt2158 2158 T/C .01 mt11914, mt13879 G, C .01 .838
 mt2706 2706 G/A .38 mt7028 C .38 .982
 mt3010 3010 G/A .23 mt3010 tSNP
 mt3197 3197 T/C .06 mt9477 A .05 .959
 mt3348 3348 A/G .02 mt3348 tSNP
 mt3394 3394 T/C .01 mt3394 tSNP
 mt3480 3480 A/G .09 mt1189, mt9716 T, T .90 .988
 mt3505 3505 A/G .05 mt11674 T .05 .978
 mt3720 3720 A/G .01 mt5426, mt12372 C, A .01 1
 mt3915 3915 G/A .01 mt3915 tSNP
 mt3990 3990 C/T .01 mt10915, mt15924 C, G .01 1
 mt3992 3992 C/T .02 mt7028, mt9123 C, A .02 .9
 mt4024 4024 A/G .02 mt7028, mt9123 C,A .02 1
 mt4216 4216 T/C .22 mt12705, mt9123, mt11719, mt12372 C, G, A, G .21 .969
 mt4336 4336 T/C .02 mt4336 tSNP
 mt4529 4529 A/T .03 mt9123, mt10034 G, C .03 1
 mt4561 4561 T/C .02 mt709, mt9716 A, C .02 .847
 mt4580 4580 G/A .07 mt7028, mt11719, mt15218 T, G, A .08 .844
 mt4639 4639 T/C .02 mt8869 G .02 .88
 mt4769 4769 G/A .02 mt4769 tSNP
 mt4793 4793 A/G .01 mt4793 tSNP
 mt4917 4917 A/G .11 mt11812, mt12633 A, C .89 .978
 mt4928 4928 T/C .02 mt4928 tSNP
 mt5004 5004 T/C .02 mt7028, mt9123 C, A .02 .907
 mt5046 5046 G/A .05 mt709, mt12705 A, T .05 1
 mt5147 5147 G/A .05 mt709, mt930 A, A .05 .953
 mt5263 5263 C/T .01 mt8869 G .02 .865
 mt5390 5390 A/G .01 mt12372, mt13020 A, C .01 .922
 mt5426 5426 T/C .02 mt5426 tSNP
 mt5460 5460 G/A .07 mt11674, mt13879 C, T .94 .857
 mt5465 5465 T/C .02 mt5465 tSNP
 mt5495 5495 T/C .03 mt5495 tSNP
 mt5656 5656 A/G .02 mt5656 tSNP
 mt6045 6045 C/T .01 mt5426, mt13020 C, C .01 1
 mt6152 6152 T/C .01 mt5426, mt11812 C, A .01 .922
 mt6221 6221 T/C .02 mt12705, mt14470, mt15884 T, C, G .02 .898
 mt6260 6260 G/A .01 mt6260 tSNP
 mt6365 6365 T/C .02 mt6365 tSNP
 mt6371 6371 C/T .02 mt11674, mt12705, mt14470 C, T, C .02 1
 mt6719 6719 T/C .01 mt6719 tSNP
 mt6734 6734 G/A .01 mt10034, mt10915 C, C .01 .844
 mt6776 6776 T/C .04 mt6776 tSNP
 mt7028 7028 T/C .38 mt7028 tSNP
 mt7476 7476 C/T .01 mt13708, mt15257 A, A .01 1
 mt7768 7768 A/G .03 mt10034, mt14182 T, C .03 1
 mt7864 7864 C/T .04 mt709, mt12705, mt15784 A, T, T .05 .95
 mt8251 8251 G/A .08 mt12633, mt12705, mt13020, mt13105, mt13708, mt13734, mt13879, mt13934, mt13965, mt13966, mt14182 C, T, T, A, G, T, T, C, T, A, T .09 .959
 mt8269 8269 G/A .03 mt8269 tSNP
 mt8557 8557 G/A .01 mt8269, mt13708 A, A .01 .916
 mt8616 8616 G/T .01 mt10915, mt12705 C, T .01 .844
 mt8697 8697 G/A .11 mt11812, mt12633 A, C .89 .946
 mt8705 8705 T/C .01 mt8705 tSNP
 mt8869 8869 A/G .02 mt8869 tSNP
 mt8994 8994 G/A .05 mt709, mt12705 A, T .05 .978
 mt9055 9055 G/A .10 mt1189, mt9716 T, T .90 .988
 mt9093 9093 A/G .01 mt11377, mt12372 A, A .01 .922
 mt9123 9123 G/A .04 mt9123 tSNP
 mt9150 9150 A/G .01 mt9150 tSNP
 mt9477 9477 G/A .05 mt9477 tSNP
 mt9612 9612 G/A .01 mt4928, mt11719 C, A .01 1
 mt9667 9667 A/G .01 mt9667 tSNP
 mt9698 9698 T/C .10 mt1189, mt9716 T, T .90 .964
 mt9716 9716 T/C .02 mt9716 tSNP
 mt9899 9899 T/C .02 mt9899 tSNP
 mt9947 9947 G/A .01 mt10034, mt10915 C, C .01 .916
 mt10034 10034 T/C .03 mt10034 tSNP
 mt10044 10044 A/G .02 mt8269, mt9123, mt15884 A, A, G .02 .932
 mt10084 10084 T/C .01 mt10084 tSNP
 mt10238 10238 T/C .05 mt5465, mt10034 T, T .95 .884
 mt10398 10398 A/G .20 mt1189, mt13708, mt10034 T, G, T .78 .855
 mt10463 10463 T/C .11 mt11812, mt12633 A, C .89 .978
 mt10550 10550 A/G .08 mt1189, mt9716 T, T .90 .853
 mt10876 10876 A/G .01 mt12372, mt13020 A, C .01 1
 mt10915 10915 T/C .02 mt10915 tSNP
 mt11251 11251 A/G .22 mt11812, mt12633, mt13708 A, C, G .77 .905
 mt11299 11299 T/C .10 mt1189, mt9716 T, T .90 1
 mt11377 11377 G/A .02 mt11377 tSNP
 mt11467 11467 A/G .20 mt12372, mt12705 A, C .20 .993
 mt11470 11470 A/G .01 mt1189, mt15924 C, G .01 1
 mt11485 11485 T/C .02 mt11485 tSNP
 mt11674 11674 C/T .05 mt11674 tSNP
 mt11719 11719 A/G .47 mt11719 tSNP
 mt11812 11812 A/G .08 mt11812 tSNP
 mt11840 11840 C/T .01 mt1189, mt6260 C, A .01 1
 mt11914 11914 G/A .02 mt11914 tSNP
 mt11947 11947 A/G .05 mt709, mt12705 A, T .05 1
 mt12007 12007 G/A .01 mt12007 tSNP
 mt12239 12239 C/C .01 mt5465, mt6719 C, C .01 .908
 mt12308 12308 A/G .20 mt12372, mt12705 A, C .20 1
 mt12372 12372 G/A .20 mt12372 tSNP
 mt12414 12414 T/C .02 mt12414 tSNP
 mt12501 12501 G/A .03 mt709, mt12705, mt14470 G, T, T .03 .936
 mt12612 12612 A/G .11 mt12372, mt12705, mt11719, mt13708, mt1189 G, C, A, A, T .11 1
 mt12618 12618 G/A .02 mt5656, mt14182, mt14470 G, C, T .02 .943
 mt12633 12633 C/A .03 mt12633 tSNP
 mt12669 12669 C/T .02 mt5495, mt14793 C, A .02 1
 mt12705 12705 C/T .11 mt12705 tSNP
 mt13020 13020 T/C .02 mt13020 tSNP
 mt13105 13105 A/G .01 mt13105 tSNP
 mt13368 13368 G/A .11 mt11812, mt12633 A, C .89 .989
 mt13617 13617 T/C .05 mt9477 A .05 1
 mt13708 13708 G/A .12 mt13708 tSNP
 mt13734 13734 T/C .02 mt13734 tSNP
 mt13740 13740 T/C .01 mt1189, mt6260 C, A .01 1
 mt13780 13780 A/G .03 mt12705, mt15043 T, A .03 1
 mt13879 13879 T/C .01 mt13879 tSNP
 mt13934 13934 C/T .02 mt13934 tSNP
 mt13965 13965 T/C .02 mt13965 tSNP
 mt13966 13966 A/G .02 mt13966 tSNP
 mt14022 14022 A/G .01 mt6719, mt9123 C, A .01 1
 mt14167 14167 C/T .10 mt1189, mt9716 T, T .90 1
 mt14182 14182 T/C .03 mt14182 tSNP
 mt14233 14233 A/G .08 mt11812 G .08 .942
 mt14365 14365 C/T .02 mt7028, mt9123 C, A .02 1
 mt14470 14470 T/C .03 mt14470 tSNP
 mt14582 14582 A/G .02 mt7028, mt9123 C, A .02 1
 mt14687 14687 A/G .02 mt13965 C .02 .932
 mt14766 14766 T/C .47 mt11719, mt11812 G, A .47 .966
 mt14793 14793 A/G .03 mt14793 tSNP
 mt14798 14798 T/C .18 mt14798 tSNP
 mt14905 14905 G/A .11 mt11812, mt12633 A, C .89 .989
 mt15043 15043 G/A .04 mt15043 tSNP
 mt15218 15218 A/G .02 mt15218 tSNP
 mt15257 15257 G/A .02 mt15257 tSNP
 mt15452 15452 C/A .22 mt12372, mt12705, mt11719 G, C, A .23 .904
 mt15607 15607 A/G .11 mt11812, mt12633 A, C .89 .989
 mt15746 15746 A/A .01 mt5465, mt6719 C, C .01 1
 mt15758 15758 A/G .02 mt15758 tSNP
 mt15784 15784 T/C .01 mt15784 tSNP
 mt15833 15833 C/C .02 mt15833 tSNP
 mt15884 15884 G/C .06 mt15884 tSNP
 mt15904 15904 C/T .07 mt11719, mt15218, mt7028 G, A, T .08 .844
 mt15907 15907 A/G .01 mt12372, mt13020 A, C .01 1
 mt15924 15924 A/G .06 mt15924 tSNP
 mt15928 15928 G/A .11 mt11812, mt12633 A, C .89 .978
Haplogroup:
 mt1719, mt7028, mt10398 (X) A,T,A .02 mt709, mt12705, mt15043 G, T, G .02 .868
 mt1719, mt7028, mt8251, mt10398 (I) A,T,A,G .03 mt8269, mt10034, mt14182 G, C, T .03 1
 mt4580, mt7028, mt10398 (V) A,T,A .07 mt7028, mt11719, mt15218 T, G, A .08 .844
 mt7028, mt10398, mt12308 (U) T,A,G .13 mt1189, mt12372, mt12705 T, A, C .13 .981
 mt7028, mt10398, mt13708 (J) T,G,A .10 mt7028, mt12705, mt13708 T, C, A .11 .934
 mt7028, mt8251, mt10398 (W) T,A,A .06 mt12705, mt13966, mt15043 T, A, G .06 .94
 mt7028, mt10398, mt13368 (T) T,A,A .11 mt11812, mt12633 A,C .89 .989
 mt7028, mt9055, mt10398, mt12308 (K) T,A,G,G .07 mt1189 C .07 .984
 mt7028, mt10398 (H) C,A .38 mt7028 C .38 .995
a

rCRS = revised Cambridge Reference Sequence (see Human Mitochondrial DNA Revised Cambridge Reference Sequence Web site).

As a framework to test common mtDNA variants for association with clinical traits (fig. 1), we first enumerated all hypotheses to be tested for association. Specifically, we sought to test for association with each phenotype for each of the individual 144 variant sites with frequency >1% as well as for the nine previously codified European haplogroups. Association tests for type 2 diabetes (the dichotomous trait) were performed by 2×2 χ2 comparisons, and, for quantitative phenotypes, by linear regression. Studywide significance (Pstudy) was empirically evaluated by permutation testing (association studies were repeated 50–1,000 times by using randomized phenotype labels within each case-control pair for diabetes and by using randomized trait values within each of five populations for quantitative traits). We also tested all pairwise combinations of single variants with a nominal P value (Pnom) <.1 (another ∼600 correlated hypotheses) for association with diabetes and BMI.55

Figure 1. .

Figure  1. 

Procedure for identification and comprehensive disease-association testing of all common variants in the mtDNA coding region. 1 and 2, A total of 928 mtDNA sequences of European origin were aligned to identify 144 variants with frequency >1%. 3, tSNPs and multimarker haplotypes of tSNPs were selected to capture all 144 variant sites and haplogroups with r2⩾0.8 (a haplotype of tSNPs [shaded box] captures an untyped SNP [unshaded box]). 4, tSNPs were genotyped in a diabetic case-control panel with available metabolic phenotypes. 5, All hypotheses to be tested were enumerated. 6, Association tests were performed. 7, Studywide significance of results was assessed by permutation (multiple rounds of association testing with randomization of case-control labels or, for quantitative measures, shuffling within a population).

As a test of the hypothesis that common mtDNA variation plays a causal role in disease, we considered association with type 2 diabetes and metabolic traits. We genotyped each of the 64 tSNPs in a diabetes case-control sample of 6,608 subjects, with quantitative measurements available for a subset of subjects (table 1). Under the assumption of ∼100 independent tests performed in this study, this sample has >77% power to reject the null hypothesis of no association between mtDNA variants and type 2 diabetes at P<.05 for a 5% risk allele with a 1.5 genotype relative risk and has >98% power for risk alleles with frequency >10%.56 Allele frequencies for SNPs differed across the populations tested (table 5).

Table 5. .

Allele Frequencies of SNPs and Haplogroups across Five Study Populations

Allele Frequency in Population
SNP or Haplogroup Allele Scandinavia(n = 918) Sweden(n = 1,010) Canada(n = 246) United States(n = 2,428) Poland(n = 2,006)
SNP:
 mt709 A .130 .146 .199 .136 .154
 mt750 A .029 .028 .016 .026 .013
 mt930 A .026 .031 .050 .039 .058
 mt1189 C .053 .057 .073 .075 .038
 mt1243 C .029 .011 .012 .020 .019
 mt1438 A .067 .045 .017 .039 .027
 mt1719 A .031 .053 .126 .061 .049
 mt1811 G .105 .220 .140 .160 .135
 mt1888 A .074 .112 .159 .088 .123
 mt2158 C .015 .010 .033 .010 .014
 mt2706 A .460 .431 .322 .419 .404
 mt3010 A .262 .227 .149 .229 .222
 mt3197 C .161 .107 .041 .076 .113
 mt3348 G .002 .003 .000 .002 .001
 mt3394 C .018 .007 .004 .010 .005
 mt3480 G .066 .069 .094 .099 .044
 mt3505 G .029 .011 .012 .020 .019
 mt3720 G .007 .014 .000 .015 .022
 mt3915 A .012 .035 .025 .025 .020
 mt3990 T .003 .010 .004 .007 .009
 mt3992 T .010 .018 .000 .013 .013
 mt4024 G .010 .018 .000 .013 .013
 mt4216 C .149 .217 .238 .194 .221
 mt4336 C .021 .017 .025 .023 .033
 mt4529 T .011 .025 .114 .031 .018
 mt4561 C .010 .007 .017 .017 .004
 mt4580 A .061 .050 .045 .061 .056
 mt4639 C .019 .007 .004 .004 .010
 mt4769 A .067 .045 .017 .039 .027
 mt4793 G .014 .014 .008 .021 .014
 mt4917 G .074 .112 .159 .088 .123
 mt4928 C .004 .001 .000 .000 .003
 mt5004 C .010 .018 .000 .013 .013
 mt5046 A .029 .013 .017 .019 .020
 mt5147 A .025 .030 .008 .036 .054
 mt5263 T .019 .007 .004 .004 .010
 mt5390 G .007 .014 .000 .016 .023
 mt5426 C .011 .022 .000 .020 .026
 mt5460 A .044 .021 .045 .030 .033
 mt5465 C .000 .000 .000 .001 .000
 mt5495 C .020 .023 .004 .010 .015
 mt5656 G .081 .013 .012 .014 .038
 mt6045 T .007 .015 .000 .016 .022
 mt6152 C .007 .014 .000 .016 .022
 mt6221 C .001 .020 .004 .010 .006
 mt6260 A .007 .019 .020 .012 .006
 mt6365 C .003 .001 .000 .008 .006
 mt6371 T .001 .022 .004 .012 .007
 mt6719 C .000 .002 .000 .001 .004
 mt6734 A .003 .011 .008 .007 .009
 mt6776 C .043 .028 .069 .038 .016
 mt7028 C .460 .431 .322 .419 .404
 mt7476 T .010 .033 .021 .019 .008
 mt7768 G .073 .025 .020 .038 .049
 mt7864 T .026 .011 .012 .015 .015
 mt8251 A .040 .036 .149 .060 .049
 mt8269 A .023 .022 .033 .021 .026
 mt8557 A .016 .008 .033 .010 .009
 mt8616 T .003 .010 .008 .007 .009
 mt8697 A .074 .112 .159 .088 .123
 mt8705 C .027 .016 .000 .004 .003
 mt8869 G .019 .007 .004 .004 .010
 mt8994 A .029 .013 .017 .019 .020
 mt9055 A .066 .069 .094 .099 .044
 mt9093 G .013 .008 .000 .010 .012
 mt9123 A .010 .019 .000 .014 .014
 mt9150 G .000 .009 .000 .006 .002
 mt9477 A .161 .107 .041 .076 .113
 mt9612 A .004 .001 .000 .000 .001
 mt9667 G .023 .012 .000 .010 .015
 mt9698 C .066 .069 .094 .099 .044
 mt9716 C .012 .012 .021 .023 .007
 mt9899 C .016 .023 .008 .018 .030
 mt9947 A .003 .011 .008 .007 .009
 mt10034 C .011 .028 .114 .031 .018
 mt10044 G .001 .013 .000 .007 .009
 mt10084 C .001 .005 .000 .009 .005
 mt10238 C .011 .027 .114 .032 .018
 mt10398 G .146 .204 .278 .231 .168
 mt10463 C .074 .112 .159 .088 .123
 mt10550 G .066 .069 .094 .099 .044
 mt10876 G .007 .014 .000 .016 .023
 mt10915 C .006 .012 .008 .009 .010
 mt11251 G .156 .226 .250 .212 .231
 mt11299 C .066 .069 .094 .099 .044
 mt11377 A .024 .036 .004 .023 .020
 mt11467 G .267 .248 .183 .239 .254
 mt11470 G .005 .002 .000 .014 .004
 mt11485 C .009 .021 .025 .017 .012
 mt11674 T .029 .011 .012 .020 .019
 mt11719 G .477 .470 .416 .481 .457
 mt11812 G .055 .081 .114 .064 .083
 mt11840 T .007 .017 .020 .011 .004
 mt11914 A .048 .014 .004 .041 .022
 mt11947 G .029 .013 .017 .019 .020
 mt12007 A .014 .007 .049 .012 .016
 mt12308 G .267 .248 .183 .239 .254
 mt12372 A .267 .248 .183 .239 .255
 mt12414 C .034 .012 .012 .019 .019
 mt12501 A .018 .028 .135 .050 .042
 mt12612 G .073 .099 .071 .102 .067
 mt12618 A .058 .012 .012 .013 .022
 mt12633 A .018 .030 .042 .023 .038
 mt12669 T .018 .001 .004 .000 .000
 mt12705 T .059 .065 .161 .083 .070
 mt13020 C .012 .016 .004 .017 .028
 mt13105 G .012 .009 .029 .010 .008
 mt13368 A .074 .112 .159 .088 .123
 mt13617 C .161 .107 .041 .076 .113
 mt13708 A .081 .119 .087 .123 .114
 mt13734 C .007 .017 .000 .016 .023
 mt13740 C .007 .017 .020 .011 .004
 mt13780 G .010 .028 .082 .039 .019
 mt13879 C .015 .010 .033 .010 .014
 mt13934 T .004 .015 .037 .028 .031
 mt13965 C .007 .006 .000 .005 .007
 mt13966 G .015 .028 .000 .019 .014
 mt14022 G .000 .002 .000 .000 .000
 mt14167 T .066 .069 .094 .099 .044
 mt14182 C .073 .025 .029 .040 .049
 mt14233 G .055 .081 .114 .064 .083
 mt14365 T .010 .018 .000 .013 .013
 mt14470 C .001 .030 .004 .025 .019
 mt14582 G .010 .018 .000 .013 .013
 mt14687 G .007 .006 .000 .005 .007
 mt14766 C .477 .470 .416 .480 .456
 mt14793 G .067 .077 .023 .041 .072
 mt14798 C .093 .127 .100 .176 .119
 mt14905 A .074 .112 .159 .088 .123
 mt15043 A .010 .040 .082 .047 .035
 mt15218 G .033 .053 .057 .034 .049
 mt15257 A .010 .034 .021 .022 .014
 mt15452 A .149 .219 .236 .196 .222
 mt15607 G .074 .112 .159 .088 .123
 mt15758 G .012 .014 .111 .016 .005
 mt15784 C .003 .003 .008 .012 .016
 mt15833 C .004 .015 .025 .016 .024
 mt15884 C .036 .034 .012 .032 .022
 mt15904 T .061 .050 .045 .062 .056
 mt15907 G .007 .014 .000 .016 .023
 mt15924 G .017 .047 .107 .062 .036
 mt15928 A .074 .112 .159 .088 .123
Haplogroup:
 X .015 .025 .018 .024 .030
 I .011 .025 .107 .028 .018
 V .061 .050 .045 .061 .056
 U .212 .185 .106 .163 .216
 J .075 .100 .083 .106 .083
 W .031 .013 .039 .030 .037
 T .074 .112 .159 .088 .123
 K .053 .057 .073 .075 .038
 H .460 .431 .322 .419 .404

Results from association studies with type 2 diabetes and BMI are shown in tables 6, 7, and 8. For diabetes, only two hypotheses with Pnom<.05 were found, and these results were far from significant after permutation testing (50–1,000 iterations for each association test) (Pstudy=.55). For BMI, we found no significant association before (Pstudy=1.0) or after (Pstudy=.25) adjustment for sex and age. Tests for epistasis did not demonstrate any significant association with diabetes or BMI. Subanalysis of association with diabetes by population failed to show any strong effects in U.S., Scandinavian, and Canadian populations (tables 9 and 10). A significant association result was observed in the Polish subpopulation after permutation testing (PPolishstudy=.02 after 1,000 permutations); however, given that mtDNA variants from five populations were tested for association with diabetes, this result is consistent with noise and thus would need to be validated by replication in other large Polish samples.

Table 6. .

Results of Association Testing of All mtDNA Variants with Type 2 Diabetes and Metabolic Traits

Phenotypea n Best Result Effect Estimateb (95% CI) Pnom Pempiricalc
DM 6,608 mt12612 (syn ND5) 1.25 (1.05–1.49) .011 >.55 (NS)
BMI 6,523 mt9123 (mis ND3) −.04 (−.05 to −.03) .0027 1.0 (NS)
Ins Index 342 mt3197 (16S rRNA); mt9477 (mis COIII); mt13617 (syn ND5) −.14 (−.19 to −.09) .012 >.3 (NS)
HOMA-IR 399 mt4561 (mis ND2) .102 (.052–.152) .042 >.26 (NS)
Cholesterol 1,274 mt15784 (syn cytB) .10 (.07–.13) .0003 >.08 (NS)
Systolic BP 2,047 mt4561 (mis ND2) −.045 (−.065 to −.025) .042 >.35 (NS)
Diastolic BP 2,047 mt3394 (tRNA S) .022 (−.001 to .045) .12 >.5 (NS)
a

BP = blood pressure; DM = diabetes mellitus, type 2; Ins = insulinogenic.

b

OR for DM and standardized regression coefficient (β) for all other phenotypes (the quantitative traits).

c

NS = not significant.

Table 7. .

Association Testing with Type 2 Diabetes, BMI, and Metabolic Traits[Note]

Variable Type 2 Diabetes BMI Insulinogenic
Index
HOMA-IR Cholesterol Systolic BP Diastolic BP
n 6,608 6,523 342 399 1,274 2,047 2,047
Populations All All Scandinavian/Swedish Scandinavian/Swedish All All All
Diabetics and controls Yes Yes Controls only Controls only Yes Yes Yes
Log taken Yes Yes Yes No No No
Best result mt12612 mt9123 mt3197, mt9477, mt13617 mt4561 mt15784 mt4561 mt3394
Minimum P .0106 .0027 .0439 .0415 .0003 .04 .1197
Maximum test statistic (OR or β) 1.25 −.0250 −.10 .21 2.15 −10.24 −3.550
No. of SNPs with Pnom < .05 3 26 3 2 13 1.00 0
No. of SNPs with Pnom < .01 3 26 3 2 13 1.00 0
Pstudy >.55 1.00 >.45 >.26 >.08 >.35 >.5
Adjusted Pstudy NA >.25 >.5 >.42 >.08 >.1 >.6
Adjusted for NA Age, sex Age, sex, BMI Age, sex, BMI Age, sex, BMI Age, sex, BMI Age, sex, BMI

Note.— BP = blood pressure; NA = not applicable.

Table 8. .

Results of Association Testing of Each SNP and Haplogroup with Type 2 Diabetes, BMI, and Metabolic Traits[Note]

Type 2 Diabetes BMI InsulinogenicIndex HOMA-IR Cholesterol Systolic BP Diastolic BP
SNP or Haplogroup Allele Allele Name OR (95% CI) Pnom β Pnom β Pnom β Pnom β Pnom β Pnom β Pnom Percentage of Data
SNP:
 mt709 A 12SrRNA .92 (.80–1.05) .212 −.001 .621 .02 .688 .01 .824 .09 .3860 −.91 .509 −.32 .626 99.3
 mt750 A 12SrRNA 1.08 (.78–1.50) .627 .000 .997 .01 .924 .07 .407 .15 .4683 .41 .891 −1.76 .217 99.4
 mt930 A 12SrRNA .88 (.69–1.12) .288 −.002 .744 −.06 .754 .04 .689 .01 .9745 .41 .884 .08 .951 99.1
 mt1189 C 12SrRNA .84 (.68–1.03) .100 −.002 .561 .07 .412 .02 .734 .09 .4912 .09 .965 .08 .933 99.7
 mt1243 C 12SrRNA 1.16 (.81–1.65) .424 .003 .700 .01 .953 −.05 .481 .12 .6131 .95 .793 1.27 .462 99.5
 mt1438 A 12SrRNA 1.05 (.82–1.35) .678 −.003 .619 .09 .293 .08 .120 .20 .1577 −2.80 .206 −1.38 .191 98.7
 mt1719 A 16SrRNA 1.04 (.84–1.28) .744 −.001 .752 .01 .918 .02 .790 −.08 .6530 1.00 .648 −.82 .429 98.5
 mt1811 G 16SrRNA .89 (.77–1.02) .082 .000 .989 .02 .722 .00 .903 −.09 .3176 −.57 .673 −.62 .337 97.8
 mt1888 A 16SrRNA .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt2158 C 16SrRNA 1.25 (.81–1.92) .322 −.004 .633 .23 .093 .06 .506 .26 .4245 −.22 .956 .52 .782 98.7
 mt2706 A 16SrRNA .99 (.90–1.09) .884 .002 .446 .06 .135 .01 .572 .10 .1296 −.26 .789 −.17 .717 99.7
 mt3010 A 16SrRNA .99 (.88–1.11) .854 −.004 .089 .04 .354 .01 .829 .02 .8391 −.54 .639 −.19 .725 99.0
 mt3197 C 16SrRNA 1.10 (.93–1.29) .264 −.004 .252 −.10 .044 −.03 .314 −.06 .5465 −.75 .620 −1.12 .120 98.5
 mt3348 G synND1 .37 (.10–1.34) .131 .039 .097 .04 .915 .16 .522 .05 .9285 6.53 .505 −1.38 .767 99.4
 mt3394 C misND1 1.29 (.77–2.18) .336 −.006 .571 .02 .817 .05 .473 −.74 .0141 −7.96 .097 −3.55 .120 98.5
 mt3480 G synND1 .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt3505 G misND1 1.16 (.81–1.65) .424 .003 .700 .01 .953 −.05 .481 .12 .6131 .95 .793 1.27 .462 99.5
 mt3720 G synND1 1.22 (.82–1.80) .327 .016 .041 −.31 .380 −.20 .422 .09 .8383 −2.87 .613 −1.43 .596 99.7
 mt3915 A synND1 1.05 (.76–1.45) .763 .016 .013 −.01 .959 .07 .488 .14 .5599 −3.00 .333 .58 .694 98.2
 mt3990 T synND1 1.10 (.62–1.93) .753 −.001 .941 −.35 .156 −.06 .742 .47 .3338 5.27 .387 −.89 .758 99.1
 mt3992 T misND1 .68 (.44–1.05) .081 −.025 .004 −.02 .920 −.16 .141 .16 .5830 5.72 .176 1.25 .535 99.4
 mt4024 G misND1 .68 (.44–1.05) .081 −.025 .004 −.02 .920 −.16 .141 .16 .5830 5.72 .176 1.25 .535 99.4
 mt4216 C misND1 .97 (.86–1.10) .642 .001 .566 −.07 .188 −.02 .635 .06 .5276 −.60 .629 .02 .968 98.4
 mt4336 C tRNA Q .87 (.64–1.19) .384 .001 .873 .02 .847 −.05 .511 −.17 .4813 −3.62 .293 −.80 .625 99.5
 mt4529 T synND2 1.09 (.81–1.48) .568 .013 .034 −.35 .157 −.06 .736 .34 .2124 .35 .902 1.37 .310 98.7
 mt4561 C misND2 .86 (.54–1.38) .536 −.007 .484 .03 .837 .21 .042 −.44 .2737 −10.24 .042 −2.89 .230 99.1
 mt4580 A synND2 1.18 (.96–1.46) .114 .003 .512 .09 .294 −.04 .474 .40 .0046 −3.00 .158 −.37 .715 99.5
 mt4639 C misND2 1.51 (.88–2.58) .135 −.010 .344 −.01 .978 .23 .189 −.70 .0086 .31 .946 .35 .873 99.3
 mt4769 A synND2 1.05 (.82–1.35) .678 −.003 .619 .09 .293 .08 .120 .20 .1577 −2.80 .206 −1.38 .191 98.7
 mt4793 G synND2 .96 (.65–1.41) .831 .009 .257 .10 .522 −.13 .207 −.60 .0326 .87 .833 .63 .752 99.2
 mt4917 G misND2 .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt4928 C synND2 1.51 (.43–5.30) .522 −.002 .938 −.34 .341 −.27 .263 −.59 .3957 2.00 .874 3.68 .540 99.2
 mt5004 C synND2 .68 (.44–1.05) .081 −.025 .004 −.02 .920 −.16 .141 .16 .5830 5.72 .176 1.25 .535 99.4
 mt5046 A misND2 1.10 (.77–1.55) .608 .001 .841 .02 .832 −.08 .245 .18 .4425 −2.74 .445 .10 .954 99.3
 mt5147 A synND2 .88 (.68–1.13) .314 −.001 .879 −.06 .763 .04 .684 −.05 .8222 1.76 .568 −.33 .821 98.7
 mt5263 T misND2 1.51 (.88–2.58) .135 −.010 .344 −.01 .978 .23 .189 −.70 .0086 .31 .946 .35 .873 99.3
 mt5390 G synND2 1.29 (.87–1.90) .201 .016 .042 −.31 .379 −.20 .420 .09 .8404 −2.86 .613 −1.41 .601 99.4
 mt5426 C synND2 1.08 (.76–1.52) .673 .012 .087 −.15 .453 −.06 .617 .05 .8639 −4.80 .257 −1.34 .508 99.7
 mt5460 A misND2 1.20 (.91–1.59) .187 .001 .917 .09 .277 −.01 .842 .17 .3751 .43 .873 .95 .461 99.0
 mt5465 C synND2 1.01 (.06–16.09) .997 .111 .045 99.3
 mt5495 C synND2 1.09 (.72–1.64) .683 −.009 .274 .05 .736 −.07 .425 −.24 .3009 1.61 .652 .92 .590 98.8
 mt5656 G ncnc .89 (.67–1.18) .426 −.003 .561 −.13 .062 −.06 .177 −.09 .5272 .85 .732 .53 .654 99.4
 mt6045 T synCO1 1.17 (.79–1.72) .437 .017 .033 −.31 .380 −.20 .422 .09 .8383 −2.04 .710 −.36 .889 99.7
 mt6152 C synCO1 1.19 (.81–1.76) .380 .017 .030 −.31 .380 −.20 .422 .09 .8383 −2.87 .613 −1.43 .596 99.7
 mt6221 C synCO1 1.22 (.74–2.04) .437 .003 .740 .39 .260 −.01 .973 −.05 .9119 −2.97 .526 1.16 .603 99.3
 mt6260 A synCO1 .80 (.50–1.27) .341 −.001 .908 .11 .542 .04 .758 .00 .9962 3.23 .422 −.02 .991 98.7
 mt6365 C synCO1 .94 (.49–1.83) .863 −.005 .708 .09 .712 −.09 .589 −.62 .2985 −14.10 .196 −2.14 .681 99.3
 mt6371 T synCO1 1.16 (.72–1.88) .547 .002 .832 .39 .263 −.01 .972 −.05 .9128 −1.92 .668 1.91 .372 98.9
 mt6719 C synCO1 1.60 (.53–4.84) .407 −.025 .251 .76 .5213 −11.58 .452 −4.65 .527 99.3
 mt6734 A synCO1 1.17 (.67–2.05) .575 −.003 .806 −.35 .155 −.06 .736 .11 .8173 2.63 .643 −1.13 .676 99.7
 mt6776 C synCO1 1.09 (.82–1.43) .557 .004 .438 −.04 .598 .03 .583 .20 .2676 1.76 .487 −1.25 .302 99.5
 mt7028 C synCO1 .99 (.90–1.09) .884 .002 .446 .06 .135 .01 .572 .10 .1296 −.26 .789 −.17 .717 99.7
 mt7476 T tRNA S .98 (.67–1.44) .915 .007 .393 .31 .126 .08 .555 −.39 .0993 .86 .793 −1.90 .222 98.9
 mt7768 G synCOII .87 (.69–1.11) .267 .007 .141 −.14 .054 −.02 .691 .25 .0985 2.15 .372 −.93 .418 98.0
 mt7864 T synCOII 1.14 (.78–1.69) .497 −.003 .663 .02 .832 −.10 .153 .06 .8159 −3.99 .299 −1.18 .517 99.3
 mt8251 A synCOII 1.18 (.95–1.47) .134 −.003 .437 −.07 .531 .01 .857 −.29 .1104 2.21 .332 −.51 .641 96.6
 mt8269 A nc 1.02 (.74–1.40) .911 −.016 .012 .04 .716 −.07 .332 .23 .3098 1.69 .589 .49 .745 99.2
 mt8557 A synATP8; misATP6 1.29 (.81–2.05) .281 −.016 .094 .22 .095 .06 .518 .23 .4652 −1.87 .646 −.80 .680 99.1
 mt8616 T misATP6 1.28 (.73–2.25) .381 .003 .797 −.35 .156 −.06 .742 .47 .3338 3.89 .507 −1.42 .610 99.2
 mt8697 A synATP6 .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt8705 C misATP6 1.04 (.61–1.76) .896 −.016 .122 .01 .896 −.06 .396 −.18 .4415 3.75 .277 −.65 .694 99.5
 mt8869 G misATP6 1.51 (.88–2.58) .135 −.010 .344 −.01 .978 .23 .189 −.70 .0086 .31 .946 .35 .873 99.3
 mt8994 A synATP6 1.10 (.77–1.55) .608 .001 .841 .02 .832 −.08 .245 .18 .4425 −2.74 .445 .10 .954 99.3
 mt9055 A misATP6 .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt9093 G synATP6 1.52 (.93–2.47) .091 .001 .892 −.01 .955 −.01 .933 −.27 .3518 1.86 .706 2.51 .285 99.3
 mt9123 A synATP6 .76 (.50–1.15) .194 −.025 .003 −.02 .928 −.16 .146 .16 .5823 5.72 .178 1.25 .537 99.0
 mt9150 G synATP6 2.38 (1.07–5.32) .034 .030 .048 .53 .3708 .15 .985 1.49 .687 99.5
 mt9477 A misCOIII 1.10 (.93–1.29) .264 −.004 .252 −.10 .044 −.03 .314 −.06 .5465 −.75 .620 −1.12 .120 98.5
 mt9612 A misCOIII 2.51 (.52–12.26) .254 −.041 .246 −.34 .341 −.27 .263 −.59 .3957 2.00 .874 3.68 .540 99.2
 mt9667 G misCOIII 1.27 (.83–1.94) .280 −.001 .929 −.09 .474 −.04 .687 .55 .0268 −1.50 .709 1.29 .500 99.6
 mt9698 C synCOIII .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt9716 C synCOIII .80 (.54–1.20) .290 −.008 .320 .01 .936 .09 .284 .12 .7185 −4.65 .290 −1.34 .524 98.8
 mt9899 C synCOIII 1.04 (.74–1.45) .826 −.002 .765 .17 .214 .02 .798 .26 .3337 1.25 .726 −.53 .755 98.7
 mt9947 A misCOIII 1.17 (.67–2.05) .575 −.003 .806 −.35 .155 −.06 .736 .11 .8173 2.63 .643 −1.13 .676 99.7
 mt10034 C tRNA G 1.08 (.80–1.46) .602 .015 .013 −.35 .155 −.06 .736 .36 .1523 .30 .915 1.15 .389 99.7
 mt10044 G tRNA G .75 (.43–1.32) .322 −.025 .030 .00 .16 .6998 9.15 .118 2.10 .453 99.0
 mt10084 C misND3 .61 (.31–1.17) .138 −.005 .705 .15 .669 .02 .938 −.41 .5478 7.00 .433 3.62 .396 99.5
 mt10238 C synND3 1.10 (.82–1.49) .523 .017 .005 −.35 .156 −.06 .739 .36 .1620 .35 .901 1.18 .375 99.0
 mt10398 G misND3 1.04 (.92–1.18) .501 .002 .464 .05 .321 .02 .588 −.05 .5965 .80 .519 .30 .617 98.6
 mt10463 C tRNA R .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt10550 G synND4L .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt10876 G synND4 1.29 (.87–1.90) .201 .016 .042 −.31 .379 −.20 .420 .09 .8404 −2.86 .613 −1.41 .601 99.4
 mt10915 C synND4 1.15 (.69–1.92) .586 −.004 .708 −.29 .151 .00 .975 .57 .1545 6.83 .187 −1.02 .679 99.2
 mt11251 G synND4 1.02 (.91–1.15) .740 −.001 .668 .05 .308 .00 .928 −.05 .5786 .13 .915 −.01 .988 96.7
 mt11299 C synND4 .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt11377 A synND4 1.09 (.79–1.50) .589 −.003 .660 .13 .272 .04 .638 −.44 .0188 1.52 .603 .04 .978 99.3
 mt11467 G synND4 .94 (.84–1.06) .314 .001 .773 .08 .050 .02 .516 .00 .9659 .50 .659 .18 .739 99.6
 mt11470 G synND4 .75 (.42–1.32) .314 .012 .277 −.07 .785 −.13 .354 .09 .8644 2.33 .779 −.54 .891 99.7
 mt11485 C synND4 1.03 (.69–1.53) .893 −.005 .505 .11 .539 .04 .760 −.07 .7835 1.58 .679 −1.05 .564 99.2
 mt11674 T synND4 1.16 (.81–1.65) .424 .003 .700 .01 .953 −.05 .481 .12 .6131 .95 .793 1.27 .462 99.5
 mt11719 G synND4 1.04 (.95–1.15) .399 .001 .592 .03 .463 .02 .485 .02 .7837 .55 .574 .00 .996 99.6
 mt11812 G synND4 .87 (.73–1.05) .158 −.003 .417 −.03 .760 −.04 .497 .09 .4970 −1.49 .416 −.53 .541 99.5
 mt11840 T synND4 .88 (.53–1.45) .606 .002 .830 .11 .543 .04 .764 −.20 .4944 2.51 .547 −.70 .725 99.7
 mt11914 A synND4 .91 (.69–1.21) .511 .000 .999 −.03 .737 .03 .603 −.06 .7572 −.76 .803 1.42 .328 99.2
 mt11947 G synND4 1.10 (.77–1.55) .608 .001 .841 .02 .832 −.08 .245 .18 .4425 −2.74 .445 .10 .954 99.3
 mt12007 A synND4 1.43 (.94–2.16) .095 −.005 .522 .21 .152 .04 .678 .35 .2934 −2.22 .576 −.12 .947 99.2
 mt12308 G tRNA L2 .94 (.84–1.06) .314 .001 .773 .08 .050 .02 .516 .00 .9659 .50 .659 .18 .739 99.6
 mt12372 A synND5 .94 (.84–1.05) .300 −.001 .759 −.08 .050 −.02 .516 .00 .9659 −.50 .659 −.18 .739 99.6
 mt12414 C synND5 1.15 (.81–1.62) .435 .005 .461 −.04 .696 −.09 .149 .04 .8653 −.68 .843 1.23 .454 99.4
 mt12501 A synND5 1.01 (.80–1.28) .928 .004 .408 −.32 .110 −.03 .854 .37 .1120 −1.50 .564 .37 .764 98.8
 mt12612 G synND5 1.25 (1.05–1.49) .011 −.003 .441 −.08 .229 −.04 .337 .21 .0900 −2.51 .149 −.19 .819 98.9
 mt12618 A synND5 .97 (.70–1.35) .862 .005 .443 −.13 .122 −.03 .547 −.06 .7141 2.21 .440 .20 .886 99.1
 mt12633 A synND5 .94 (.71–1.27) .703 .001 .815 .16 .228 .02 .846 .24 .3547 2.52 .409 1.18 .415 97.9
 mt12669 T synND5 1.57 (.61–4.02) .347 −.013 .510 .00 .996 −.02 .847 −.04 .9000 1.62 .767 2.51 .337 98.8
 mt12705 T synND5 1.08 (.9–1.30) .384 .002 .513 .01 .949 −.06 .272 .11 .4386 −1.69 .361 .61 .492 99.7
 mt13020 C synND5 1.18 (.83–1.67) .369 .009 .224 −.20 .325 −.13 .276 −.26 .4577 −1.10 .811 .23 .916 99.5
 mt13105 G misND5 1.06 (.65–1.72) .812 −.005 .610 .04 .841 .29 .042 −.26 .3799 1.36 .748 .96 .636 98.8
 mt13368 A synND5 .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt13617 C synND5 1.10 (.93–1.29) .264 −.004 .252 −.10 .044 −.03 .314 −.06 .5465 −.75 .620 −1.12 .120 98.5
 mt13708 A misND5 1.15 (.98–1.34) .079 .001 .859 .06 .340 .02 .609 −.21 .0768 1.54 .342 .27 .727 99.0
 mt13734 C synND5 1.18 (.80–1.73) .399 .016 .047 −.31 .375 −.20 .418 .08 .8423 −1.24 .816 −1.49 .559 98.4
 mt13740 C synND5 .88 (.53–1.45) .606 .002 .830 .11 .543 .04 .764 −.20 .4944 2.51 .547 −.70 .725 99.7
 mt13780 G misND5 1.22 (.91–1.62) .187 .013 .025 −.35 .155 −.06 .736 .36 .1937 .13 .966 1.29 .376 99.4
 mt13879 C misND5 1.27 (.83–1.96) .272 −.003 .768 .22 .095 .06 .518 .25 .4270 −.26 .947 .51 .788 99.5
 mt13934 T misND5 1.00 (.73–1.37) .988 .010 .132 −.08 .815 .11 .521 .33 .4052 −1.80 .670 1.92 .341 99.0
 mt13965 C synND5 .73 (.38–1.38) .333 −.006 .659 −.13 .457 −.11 .323 1.21 .0076 −2.09 .741 −.60 .843 97.3
 mt13966 G misND5 .90 (.63–1.3) .574 −.007 .365 .17 .283 −.08 .405 −.24 .3534 .32 .926 1.40 .395 99.5
 mt14022 G synND5 99.3
 mt14167 T synND6 .84 (.69–1.01) .059 −.004 .298 .06 .436 .04 .395 .10 .4205 −.77 .683 −.17 .845 98.7
 mt14182 C synND6 .88 (.69–1.11) .279 .007 .144 −.14 .054 −.02 .691 −.25 .0985 1.77 .456 −1.05 .354 98.2
 mt14233 G synND6 .87 (.73–1.05) .158 −.003 .417 −.03 .760 −.04 .497 .09 .4970 −1.49 .416 −.53 .541 99.5
 mt14365 T synND6 .68 (.44–1.05) .081 −.025 .004 −.02 .920 −.16 .141 .16 .5830 5.72 .176 1.25 .535 99.4
 mt14470 C synND6 1.28 (.90–1.81) .170 .005 .488 .40 .252 −.01 .984 −.33 .3817 2.31 .558 1.83 .327 98.2
 mt14582 G misND6 .68 (.44–1.05) .081 −.025 .004 −.02 .920 −.16 .141 .16 .5830 5.72 .176 1.25 .535 99.4
 mt14687 G tRNA E .73 (.38–1.38) .333 −.006 .659 −.13 .457 −.11 .323 1.21 .0076 −2.09 .741 −.60 .843 97.3
 mt14766 C misCyt B 1.04 (.95–1.15) .405 −.001 .624 −.03 .463 −.02 .485 −.02 .7837 −.55 .574 .00 .996 99.4
 mt14793 G misCyt B 1.16 (.94–1.42) .174 −.003 .489 −.11 .211 .06 .260 −.06 .6519 1.38 .498 .58 .544 96.8
 mt14798 C misCyt B .93 (.81–1.07) .296 −.002 .591 .05 .371 .04 .274 .03 .8101 1.13 .473 .59 .427 99.2
 mt14905 A synCyt B .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt15043 A synCyt B 1.03 (.80–1.32) .846 .013 .012 −.35 .155 −.06 .749 .28 .2715 −1.49 .591 .67 .613 98.5
 mt15218 G misCyt B 1.16 (.91–1.48) .232 −.007 .133 −.15 .137 −.09 .223 .11 .5128 2.70 .251 .99 .380 98.8
 mt15257 A misCyt B .87 (.61–1.23) .428 .006 .393 .31 .126 .09 .549 −.45 .0515 .39 .903 −1.94 .207 99.5
 mt15452 A misCyt B .96 (.85–1.09) .538 .002 .497 −.07 .156 −.02 .569 .06 .4695 −.60 .625 .00 .995 99.2
 mt15607 G synCyt B .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 mt15758 G misCyt B .90 (.61–1.34) .603 .017 .030 −.13 .608 .13 .450 −.02 .9565 −2.87 .359 2.26 .130 98.9
 mt15784 C synCyt B .94 (.58–1.51) .795 −.001 .937 .18 .459 2.15 .0003 10.48 .176 1.97 .594 99.6
 mt15833 C synCyt B 1.14 (.78–1.65) .508 .003 .696 .20 .430 −.30 .086 .23 .5210 .58 .898 1.76 .411 99.5
 mt15884 C misCyt B 1.00 (.74–1.34) .987 .002 .748 −.01 .902 −.08 .174 .04 .8212 1.96 .473 .88 .498 94.3
 mt15904 T tRNA T 1.18 (.96–1.45) .122 .003 .513 .09 .295 −.04 .481 .40 .0047 −3.02 .155 −.38 .707 99.0
 mt15907 G tRNA T 1.29 (.87–1.90) .201 .016 .042 −.31 .379 −.20 .420 .09 .8404 −2.86 .613 −1.41 .601 99.4
 mt15924 G tRNA T 1.00 (.79–1.26) .989 .011 .017 −.11 .470 −.09 .351 −.08 .6910 .88 .717 .77 .507 98.6
 mt15928 A tRNA T .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
Haplogroup:
 X .88 (.64–1.20) .410 −.010 .098 .10 .480 −.01 .921 −.20 .4564 −1.14 .736 1.43 .373 98.8
 I 1.07 (.78–1.46) .677 .015 .016 −.35 .156 −.06 .736 .34 .2121 .63 .828 1.75 .208 98.8
 V 1.18 (.96–1.46) .114 .003 .512 .09 .294 −.04 .474 .40 .0046 −3.00 .158 −.37 .715 99.5
 U .99 (.87–1.12) .857 .000 .989 .12 .010 .03 .369 .05 .5499 .74 .558 .24 .694 99.3
 J 1.23 (1.04–1.45) .017 −.003 .452 −.06 .379 −.03 .500 .21 .0822 −2.02 .241 −.25 .763 98.9
 W .98 (.74–1.30) .882 −.003 .589 .00 .973 −.07 .274 .25 .2813 −3.03 .353 .06 .969 99.4
 T .89 (.76–1.05) .160 −.002 .560 .04 .639 −.03 .585 .13 .2933 −.49 .761 −.07 .923 97.5
 K .84 (.68–1.03) .100 −.002 .564 .07 .412 .02 .734 .09 .4912 .09 .965 .08 .933 99.7
 H .99 (.90–1`.09) .884 .002 .446 .06 .135 .01 .572 .10 .1296 −.26 .789 −.17 .717 99.7

Note.— Some SNPs were monomorphic for subsets of individuals used for analysis; hence, values for those SNPs are missing. Standardized regression coefficients (β) for best results are listed in table 6. BP = blood pressure.

Table 9. .

Results of Association Testing of All mtDNA Variants with Type 2 Diabetes, by Population

Sample n Best Result OR (95% CI) Pnom Pempiricala
Scandinavian 918 mt8869 (misATP6); mt5263 (misND2); mt4639 (misND2) 7.67 (2.18–27.04) .0015 >.5 (NS)
Swedish 1,010 mt8251 (synCOII) 2.56 (1.25–5.26) .0105 >.5 (NS)
Canadian 246 mt15218 (misCytB) 3.93 (1.16–13.28) .0277 1 (NS)
U.S.b 2,428 mt5495 (synND2) 3.60 (1.42–9.12) .0070 >.3 (NS)
Polandb 2,006 mt12612 (synND5) 2.07 (1.44–2.98) .000085 .02
a

NS = not significant.

b

Sample from Genomics Collaborative Inc.

Table 10. .

Results of Association Testing of Each SNP and Haplogroup with Type 2 Diabetes, by Population[Note]

Scandinavia Sweden Canada United States Poland
SNP or Haplogroup Allele OR (95% CI) Pnom OR (95% CI) Pnom OR (95% CI) Pnom OR (95% CI) Pnom OR (95% CI) Pnom
SNP:
 mt709 A .95 (.64–1.39) .77788 1.04 (.73–1.48) .8202 .71 (.38–1.34) .2872 .92 (.73–1.17) .5037 .87 (.69–1.11) .27722
 mt750 A 1.73 (.79–3.79) .16969 1.00 (2.12–0.47) .9957 1.02 (.14–7.34) .9868 .93 (.57–1.54) .7896 1.08 (.49–2.38) .85038
 mt930 A 1.69 (.74–3.87) .21450 .41 (.89–0.19) .0242 .70 (.22–2.24) .5437 1.17 (.77–1.76) .4637 .74 (.51–1.09) .12453
 mt1189 C .96 (.54–1.71) .88946 .76 (1.31–0.45) .3280 .61 (.23–1.61) .3185 .87 (.64–1.17) .3550 .83 (.52–1.30) .41337
 mt1243 C 1.00 (.46–2.19) .99543 4.53 (1.11–18.42) .0349 2.00 (.19–21.34) .5661 .84 (.48–1.50) .5617 1.31 (.68–2.53) .41544
 mt1438 A 1.07 (.64–1.81) .78927 .96 (1.74–0.53) .8896 1.01 (.14–7.28) .9933 1.12 (.74–1.69) .5998 1.01 (.59–1.74) .96710
 mt1719 A 2.56 (1.15–5.72) .02158 1.35 (.77–2.38) .2903 1.59 (.73–3.45) .2413 .80 (.57–1.11) .1845 .92 (.61–1.38) .68233
 mt1811 G .74 (.48–1.13) .16548 .76 (1.04–0.56) .0864 .69 (.33–1.43) .3144 .96 (.77–1.19) .7146 .97 (.75–1.25) .80347
 mt1888 A .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt2158 C .39 (.13–1.20) .10167 .67 (2.36–0.19) .5313 1.72 (.41–7.26) .4577 1.30 (.57–2.97) .5349 2.53 (1.14–5.62) .02222
 mt2706 A 1.00 (.77–1.30) .97143 1.00 (.78–1.29) .9710 .78 (.46–1.33) .3614 .97 (.82–1.13) .6678 1.04 (.87–1.25) .64907
 mt3010 A .76 (.57–1.02) .06835 1.33 (.99–1.80) .0584 .68 (.33–1.39) .2904 1.03 (.85–1.24) .7900 .96 (.78–1.19) .71873
 mt3197 C .94 (.66–1.33) .70875 1.25 (.83–1.89) .2942 1.55 (.43–5.59) .5014 1.35 (1.00–1.83) .0494 .94 (.71–1.24) .66619
 mt3348 G 1.00 (.06–16.11) .99752 .50 (5.28–0.05) .5643 .25 (.03–1.88) .1775
 mt3394 C .46 (.16–1.30) .14431 6.01 (.93–38.79) .0593 1.31 (.57–2.98) .5257 2.38 (.64–8.85) .19679
 mt3480 G .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt3505 G 1.00 (.46–2.19) .99543 4.53 (1.11–18.42) .0349 2.00 (.19–21.34) .5661 .84 (.48–1.50) .5617 1.31 (.68–2.53) .41544
 mt3720 G .99 (.20–4.95) .99357 2.50 (.81–7.72) .1113 1.47 (.76–2.84) .2472 .87 (.48–1.58) .64860
 mt3915 A .57 (.17–1.92) .36280 1.13 (.57–2.24) .7270 .50 (.09–2.70) .4200 1.40 (.83–2.34) .2072 .85 (.45–1.61) .62083
 mt3990 T .51 (.05–5.43) .57874 1.51 (.43–5.32) .5250 1.13 (.43–2.92) .8090 .90 (.34–2.33) .82373
 mt3992 T .80 (.21–2.98) .73763 1.00 (2.53–0.39) .9932 .68 (.34–1.38) .2824 .49 (.22–1.09) .08073
 mt4024 G .80 (.21–2.98) .73763 1.00 (2.53–0.39) .9932 .68 (.34–1.38) .2824 .49 (.22–1.09) .08073
 mt4216 C .74 (.51–1.07) .11273 .99 (1.33–0.73) .9280 .63 (.34–1.14) .1273 1.14 (.93–1.40) .1960 .93 (.76–1.15) .52925
 mt4336 C .58 (.23–1.46) .24638 1.45 (.55–3.81) .4554 2.03 (.38–10.95) .4084 .64 (.37–1.09) .1008 1.03 (.63–1.68) .89781
 mt4529 T 4.04 (.96–17.01) .05732 1.07 (.49–2.38) .8594 1.63 (.74–3.63) .2284 .76 (.48–1.21) .2515 1.26 (.65–2.45) .49148
 mt4561 C .12 (.02–0.71) .01937 2.46 (.50–12.1) .2664 .98 (.14–7.10) .9866 .82 (.45–1.51) .5282 2.51 (.51–12.27) .25489
 mt4580 A 2.20 (1.25–3.87) .00611 1.52 (.86–2.71) .1529 .84 (.25–2.83) .7790 1.05 (.75–1.46) .7945 .96 (.66–1.41) .83729
 mt4639 C 7.67 (2.18–27.04) .00153 .40 (1.96–0.08) .2597 .66 (.19–2.34) .5228 1.23 (.51–2.98) .64660
 mt4769 A 1.07 (.64–1.81) .78927 .96 (1.74–0.53) .8896 1.01 (.14–7.28) .9933 1.12 (.74–1.69) .5998 1.01 (.59–1.74) .96710
 mt4793 G 1.18 (.39–3.53) .76772 .55 (1.63–0.19) .2800 1.03 (.06–16.58) .9860 .99 (.56–1.73) .9596 1.08 (.50–2.30) .84636
 mt4917 G .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt4928 C 3.10 (.36–26.62) .30349 .67 (.11–3.97) .65919
 mt5004 C .80 (.21–2.98) .73763 1.00 (2.53–0.39) .9932 .68 (.34–1.38) .2824 .49 (.22–1.09) .08073
 mt5046 A 1.00 (.46–2.19) .99095 3.31 (.97–11.25) .0556 2.97 (.34–26.13) .3254 .67 (.37–1.21) .1830 1.37 (.73–2.57) .33308
 mt5147 A 1.57 (.68–3.65) .29093 .36 (.80–0.16) .0116 1.24 (.81–1.90) .3296 .76 (.52–1.12) .16931
 mt5263 T 7.67 (2.18–27.04) .00153 .40 (1.96–0.08) .2597 .66 (.19–2.34) .5228 1.23 (.51–2.98) .64660
 mt5390 G 1.00 (.20–5.00) .99571 2.53 (.82–7.79) .1072 1.61 (.84–3.06) .1492 .92 (.51–1.65) .77333
 mt5426 C .66 (.19–2.33) .51804 1.75 (.74–4.17) .2041 1.34 (.76–2.37) .3124 .79 (.45–1.37) .39715
 mt5460 A .73 (.38–1.38) .33182 1.64 (.68–3.95) .2742 1.80 (.52–6.20) .3546 1.00 (.63–1.60) .9943 1.73 (1.04–2.86) .03442
 mt5465 C 1.00 (.06–15.98) .9991
 mt5495 C 1.26 (.49–3.21) .63062 .78 (1.78–0.34) .5495 3.60 (1.42–9.12) .0070 .52 (.24–1.12) .09332
 mt5656 G .89 (.55–1.43) .62761 .44 (1.40–0.14) .1650 2.02 (.19–21.5) .5613 .94 (.47–1.86) .8515 .95 (.60–1.50) .81851
 mt6045 T .99 (.20–4.95) .99357 2.00 (.69–5.77) .2001 1.38 (.72–2.64) .3266 .87 (.48–1.58) .64860
 mt6152 C .99 (.20–4.95) .99357 2.50 (.81–7.72) .1113 1.38 (.72–2.64) .3266 .87 (.48–1.58) .64860
 mt6221 C 1.51 (.61–3.69) .3711 .92 (.42–2.02) .8309 1.60 (.53–4.86) .40589
 mt6260 A .50 (.09–2.64) .41267 .89 (2.20–0.36) .7960 .66 (.11–3.98) .6514 .87 (.42–1.79) .7082 .72 (.23–2.26) .56962
 mt6365 C .50 (.05–5.27) .56306 1.22 (.50–2.94) .6641 .84 (.25–2.75) .76877
 mt6371 T 1.19 (.51–2.78) .6872 1.00 (.48–2.05) .9909 1.60 (.53–4.84) .40999
 mt6719 C 2.00 (.19–21.04) .5649
 mt6734 A .50 (.05–5.27) .56306 1.20 (.36–3.95) .7643 1.28 (.47–3.43) .6288 1.01 (.40–2.55) .98979
 mt6776 C .61 (.32–1.17) .13893 .86 (1.82–0.40) .6896 1.48 (.55–4.00) .4403 1.21 (.80–1.85) .3696 1.68 (.82–3.42) .15645
 mt7028 C 1.00 (.77–1.30) .97143 1.00 (.78–1.29) .9710 .78 (.46–1.33) .3614 .97 (.82–1.13) .6678 1.04 (.87–1.25) .64907
 mt7476 T 1.26 (.34–4.69) .73514 .94 (1.89–0.47) .8687 .24 (.03–1.84) .1693 .95 (.52–1.71) .8560 1.51 (.54–4.23) .43224
 mt7768 G .94 (.56–1.56) .80245 .46 (1.05–0.20) .0638 .67 (.11–4.01) .6580 1.12 (.74–1.71) .5869 .79 (.52–1.19) .25418
 mt7864 T 1.01 (.45–2.27) .98696 4.46 (1.09–18.21) .0370 .63 (.32–1.23) .1775 1.43 (.68–2.99) .34545
 mt8251 A 1.99 (.99–4.00) .05416 2.56 (1.25–5.26) .0105 1.91 (.92–3.97) .0834 .82 (.58–1.15) .2553 1.11 (.74–1.68) .61329
 mt8269 A .50 (.20–1.24) .13380 1.00 (.43–2.33) .9962 1.70 (.40–7.15) .4721 1.08 (.62–1.90) .7795 1.18 (.68–2.05) .55420
 mt8557 A .40 (.13–1.24) .11350 1.68 (.4–6.95) .4760 1.70 (.40–7.15) .4721 1.50 (.68–3.34) .3168 2.03 (.77–5.32) .15049
 mt8616 T .51 (.05–5.43) .57874 1.51 (.43–5.32) .5250 1.43 (.55–3.75) .4663 1.01 (.40–2.55) .98461
 mt8697 A .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt8705 C 1.28 (.58–2.84) .54662 1.29 (.48–3.48) .6142 .50 (.13–1.95) .3164 .66 (.11–3.93) .65108
 mt8869 G 7.67 (2.18–27.04) .00153 .40 (1.96–0.08) .2597 .66 (.19–2.34) .5228 1.23 (.51–2.98) .64660
 mt8994 A 1.00 (.46–2.19) .99095 3.31 (.97–11.25) .0556 2.97 (.34–26.13) .3254 .67 (.37–1.21) .1830 1.37 (.73–2.57) .33308
 mt9055 A .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt9093 G 1.42 (.45–4.48) .55082 .59 (2.46–0.14) .4725 1.77 (.79–3.97) .1688 1.88 (.80–4.40) .14472
 mt9123 A .79 (.21–2.97) .73265 1.10 (.44–2.73) .8340 .78 (.40–1.54) .4743 .55 (.26–1.19) .12787
 mt9150 G 2.02 (.52–7.89) .3137 1.82 (.62–5.35) .2795
 mt9477 A .94 (.66–1.33) .70875 1.25 (.83–1.89) .2942 1.55 (.43–5.59) .5014 1.35 (1.00–1.83) .0494 .94 (.71–1.24) .66619
 mt9612 A 3.10 (.36–26.62) .30349 1.01 (.06–16.11) .99660
 mt9667 G .91 (.38–2.17) .83321 .71 (2.24–0.23) .5590 2.45 (1.04–5.77) .0398 1.23 (.59–2.56) .58585
 mt9698 C .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt9716 C .10 (.02–0.52) .00640 1.41 (.45–4.44) .5613 .66 (.11–3.94) .6447 .85 (.49–1.45) .5463 1.33 (.46–3.84) .59560
 mt9899 C .66 (.23–1.85) .42724 1.57 (.68–3.64) .2914 1.09 (.59–2.00) .7912 1.04 (.62–1.74) .89486
 mt9947 A .50 (.05–5.27) .56306 1.20 (.36–3.95) .7643 1.28 (.47–3.43) .6288 1.01 (.40–2.55) .98979
 mt10034 C 4.05 (.96–17.07) .05642 .86 (1.83–0.41) .7015 1.63 (.74–3.63) .2284 .82 (.51–1.29) .3891 1.26 (.65–2.45) .49152
 mt10044 G .86 (2.57–0.29) .7829 .63 (.25–1.63) .3422 .70 (.27–1.84) .47261
 mt10084 C 1.51 (.25–8.96) .6507 .61 (.26–1.47) .2748 .42 (.11–1.58) .20139
 mt10238 C 4.17 (1.00–17.5) .05071 .93 (1.99–0.43) .8453 1.65 (.74–3.66) .2195 .84 (.53–1.33) .4550 1.21 (.62–2.36) .58387
 mt10398 G .89 (.61–1.28) .52021 1.10 (.81–1.50) .5386 1.01 (.57–1.77) .9810 .93 (.77–1.13) .4784 1.28 (1.01–1.62) .04098
 mt10463 C .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt10550 G .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt10876 G 1.00 (.20–5.00) .99571 2.53 (.82–7.79) .1072 1.61 (.84–3.06) .1492 .92 (.51–1.65) .77333
 mt10915 C .68 (.11–4.07) .67551 1.41 (.45–4.44) .5613 1.10 (.47–2.60) .8280 1.01 (.42–2.44) .98377
 mt11251 G .76 (.53–1.10) .14209 1.06 (.79–1.43) .6847 .66 (.37–1.20) .1761 1.09 (.90–1.33) .3731 1.08 (.87–1.33) .49302
 mt11299 C .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt11377 A 1.22 (.52–2.84) .65089 .99 (1.93–0.51) .9854 .99 (.58–1.68) .9624 1.36 (.72–2.55) .34438
 mt11467 G .82 (.61–1.10) .19156 .76 (1.01–0.57) .0625 .85 (.44–1.62) .6208 1.06 (.88–1.28) .5415 .99 (.81–1.21) .91817
 mt11470 G .67 (.11–3.97) .65737 .99 (15.94–0.06) .9966 .89 (.45–1.75) .7298 .33 (.07–1.52) .15606
 mt11485 C 1.03 (.26–4.13) .96985 1.10 (.46–2.61) .8291 .50 (.09–2.72) .4259 1.16 (.63–2.16) .6346 .92 (.41–2.10) .84714
 mt11674 T 1.00 (.46–2.19) .99543 4.53 (1.11–18.42) .0349 2.00 (.19–21.34) .5661 .84 (.48–1.50) .5617 1.31 (.68–2.53) .41544
 mt11719 G .84 (.65–1.09) .19783 1.12 (.88–1.44) .3564 .98 (.59–1.63) .9394 .98 (.83–1.15) .7929 1.02 (.86–1.22) .81946
 mt11812 G 1.00 (.56–1.76) .99367 .66 (1.04–0.42) .0742 .73 (.33–1.61) .4352 1.10 (.79–1.52) .5829 .80 (.58–1.10) .16912
 mt11840 T .50 (.09–2.65) .41575 1.12 (.43–2.93) .8164 .66 (.11–3.94) .6447 .86 (.39–1.85) .6918 1.00 (.25–4.01) .99887
 mt11914 A .99 (.54–1.82) .97616 .75 (2.16–0.26) .5877 .88 (.58–1.31) .5197 .91 (.50–1.66) .76814
 mt11947 G 1.00 (.46–2.19) .99095 3.31 (.97–11.25) .0556 2.97 (.34–26.13) .3254 .67 (.37–1.21) .1830 1.37 (.73–2.57) .33308
 mt12007 A .44 (.14–1.39) .16011 1.34 (.30–5.98) .7025 3.21 (.90–11.42) .0710 .93 (.45–1.93) .8377 2.92 (1.35–6.33) .00662
 mt12308 G .82 (.61–1.10) .19156 .76 (1.01–0.57) .0625 .85 (.44–1.62) .6208 1.06 (.88–1.28) .5415 .99 (.81–1.21) .91817
 mt12372 A .82 (.61–1.10) .19156 .76 (1.01–0.57) .0625 .85 (.44–1.62) .6208 1.06 (.88–1.28) .5415 .98 (.80–1.20) .87760
 mt12414 C .93 (.45–1.90) .84046 3.03 (.87–10.57) .0820 2.03 (.19–21.66) .5564 .87 (.49–1.56) .6462 1.38 (.72–2.65) .32421
 mt12501 A 4.47 (1.41–14.21) .01107 1.31 (.62–2.80) .4793 1.82 (.85–3.89) .1220 .78 (.54–1.12) .1775 .86 (.56–1.34) .50957
 mt12612 G .68 (.41–1.13) .13447 1.44 (.95–2.19) .0861 .90 (.33–2.41) .8290 1.10 (.84–1.43) .5011 2.07 (1.44–2.98) .00009
 mt12618 A .92 (.52–1.61) .76225 .33 (1.15–0.09) .0826 2.02 (.19–21.5) .5613 1.06 (.52–2.16) .8657 1.21 (.66–2.20) .53536
 mt12633 A .60 (.22–1.65) .32172 1.75 (.83–3.69) .1396 .42 (.11–1.59) .2010 1.11 (.65–1.90) .6962 .80 (.50–1.27) .33851
 mt12669 T 1.68 (.61–4.62) .31301
 mt12705 T 1.62 (.93–2.83) .09073 1.64 (.98–2.73) .0587 2.07 (1.03–4.17) .0417 .77 (.57–1.02) .0725 1.08 (.77–1.52) .66678
 mt13020 C .83 (.25–2.73) .75609 2.23 (.79–6.29) .1305 1.48 (.80–2.75) .2130 .93 (.55–1.58) .78339
 mt13105 G 2.70 (.75–9.72) .12933 1.26 (.34–4.70) .7332 .38 (.08–1.90) .2410 .71 (.32–1.6) .4119 1.49 (.53–4.18) .44614
 mt13368 A .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt13617 C .94 (.66–1.33) .70875 1.25 (.83–1.89) .2942 1.55 (.43–5.59) .5014 1.35 (1.00–1.83) .0494 .94 (.71–1.24) .66619
 mt13708 A .70 (.43–1.13) .14564 1.37 (.93–2.01) .1113 .88 (.36–2.17) .7887 1.06 (.83–1.35) .6467 1.41 (1.07–1.87) .01525
 mt13734 C 1.00 (.20–4.96) .99566 2.21 (.78–6.25) .1336 1.28 (.68–2.42) .4442 .91 (.51–1.64) .76543
 mt13740 C .50 (.09–2.65) .41575 1.12 (.43–2.93) .8164 .66 (.11–3.94) .6447 .86 (.39–1.85) .6918 1.00 (.25–4.01) .99887
 mt13780 G 3.59 (.82–15.71) .09011 1.55 (.72–3.33) .2590 2.38 (.89–6.34) .0826 .78 (.52–1.18) .2396 1.80 (.94–3.46) .07579
 mt13879 C .39 (.13–1.22) .10522 .67 (2.36–0.19) .5292 1.71 (.41–7.20) .4650 1.41 (.62–3.17) .4107 2.53 (1.14–5.60) .02270
 mt13934 T .98 (.14–7.02) .98766 1.14 (.41–3.16) .8039 .50 (.12–1.98) .3202 1.32 (.81–2.15) .2663 .79 (.47–1.32) .36476
 mt13965 C .20 (.03–1.43) .10900 .50 (2.67–0.09) .4201 1.16 (.39–3.46) .7903 .85 (.29–2.55) .77797
 mt13966 G 1.34 (.46–3.88) .59012 1.56 (.73–3.35) .2523 .67 (.38–1.21) .1840 .70 (.33–1.47) .34686
 mt14022 G
 mt14167 T .70 (.41–1.19) .18747 .85 (1.39–0.52) .5269 .61 (.26–1.47) .2733 .85 (.65–1.11) .2230 .95 (.62–1.45) .80851
 mt14182 C .94 (.56–1.56) .80245 .46 (1.05–0.20) .0646 1.36 (.30–6.16) .6933 1.08 (.72–1.62) .7233 .78 (.52–1.18) .24376
 mt14233 G 1.00 (.56–1.76) .99367 .66 (1.04–0.42) .0742 .73 (.33–1.61) .4352 1.10 (.79–1.52) .5829 .80 (.58–1.10) .16912
 mt14365 T .80 (.21–2.98) .73763 1.00 (2.53–0.39) .9932 .68 (.34–1.38) .2824 .49 (.22–1.09) .08073
 mt14470 C 1.30 (.62–2.69) .4861 1.06 (.63–1.77) .8292 1.72 (.89–3.32) .10541
 mt14582 G .80 (.21–2.98) .73763 1.00 (2.53–0.39) .9932 .68 (.34–1.38) .2824 .49 (.22–1.09) .08073
 mt14687 G .20 (.03–1.43) .10900 .50 (2.67–0.09) .4201 1.16 (.39–3.46) .7903 .85 (.29–2.55) .77797
 mt14766 C .84 (.65–1.09) .19783 1.12 (.88–1.44) .3564 .98 (.59–1.63) .9394 .98 (.84–1.15) .8257 1.01 (.85–1.21) .87667
 mt14793 G .96 (.55–1.66) .87265 1.02 (.64–1.62) .9347 3.93 (.50–30.57) .1916 1.56 (1.03–2.35) .0356 1.05 (.75–1.48) .78017
 mt14798 C .64 (.40–1.01) .05530 1.09 (.75–1.59) .6345 .67 (.29–1.57) .3546 .94 (.77–1.16) .5936 .97 (.74–1.27) .82976
 mt14905 A .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt15043 A 3.52 (.80–15.47) .09524 1.10 (.58–2.07) .7716 2.31 (.87–6.17) .0937 .82 (.56–1.20) .2983 1.00 (.62–1.61) .98972
 mt15218 G .87 (.42–1.80) .70133 .89 (1.55–0.51) .6774 3.93 (1.16–13.28) .0277 1.63 (1.04–2.55) .0349 .96 (.64–1.43) .82791
 mt15257 A 1.26 (.34–4.71) .73015 .88 (1.75–0.44) .7182 .25 (.03–1.90) .1782 .96 (.56–1.66) .8895 .75 (.35–1.59) .44968
 mt15452 A .74 (.51–1.06) .09985 .97 (1.31–0.72) .8596 .63 (.34–1.14) .1275 1.11 (.90–1.35) .3229 .95 (.77–1.17) .61947
 mt15607 G .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 mt15758 G 4.55 (1.12–18.51) .03434 .55 (1.64–0.19) .2850 1.31 (.59–2.92) .5109 .49 (.25–0.94) .0325 1.50 (.43–5.30) .52502
 mt15784 C 1.96 (.19–20.80) .57476 2.00 (.19–21.07) .5654 .75 (.35–1.58) .4457 1.13 (.56–2.28) .72367
 mt15833 C .33 (.04–2.86) .31519 1.13 (.41–3.15) .8099 2.09 (.39–11.20) .3912 1.00 (.53–1.89) .9939 1.29 (.73–2.30) .37879
 mt15884 C .83 (.41–1.66) .59473 1.13 (.57–2.24) .7271 2.03 (.19–21.66) .5564 .99 (.61–1.59) .9631 1.00 (.54–1.84) .99182
 mt15904 T 2.21 (1.26–3.88) .00595 1.53 (.86–2.71) .1509 .83 (.25–2.80) .7683 1.04 (.74–1.45) .8268 .96 (.65–1.40) .82022
 mt15907 G 1.00 (.20–5.00) .99571 2.53 (.82–7.79) .1072 1.61 (.84–3.06) .1492 .92 (.51–1.65) .77333
 mt15924 G 1.51 (.54–4.26) .43223 .96 (1.73–0.53) .8923 1.45 (.64–3.30) .3698 1.04 (.74–1.44) .8366 .77 (.48–1.24) .28244
 mt15928 A .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
Haplogroup:
 X 1.36 (.47–3.93) .57301 1.25 (.56–2.77) .5881 .83 (.49–1.41) .4886 .61 (.36–1.04) .06825
 I 4.14 (.99–17.37) .05238 .92 (2.05–0.42) .8474 1.41 (.62–3.21) .4066 .80 (.49–1.30) .3599 1.21 (.62–2.36) .58179
 V 2.20 (1.25–3.87) .00611 1.52 (.86–2.71) .1529 .84 (.25–2.83) .7790 1.05 (.75–1.46) .7945 .96 (.66–1.41) .83729
 U .80 (.58–1.09) .16011 .80 (1.10–0.58) .1671 1.18 (.52–2.66) .6944 1.16 (.93–1.44) .1824 1.02 (.82–1.26) .87963
 J .68 (.41–1.12) .13275 1.46 (.96–2.21) .0787 1.02 (.41–2.54) .9689 1.07 (.83–1.39) .6023 1.79 (1.29–2.47) .00047
 W 1.01 (.48–2.15) .97179 2.25 (.71–7.14) .1672 3.76 (.85–16.73) .0819 .73 (.45–1.16) .1839 .97 (.61–1.54) .90282
 T .88 (.53–1.46) .62894 .86 (1.27–0.58) .4465 .61 (.30–1.23) .1654 1.11 (.84–1.47) .4713 .79 (.60–1.03) .08576
 K .96 (.54–1.71) .88946 .76 (1.31–0.45) .3280 .61 (.23–1.61) .3185 .87 (.64–1.17) .3550 .83 (.52–1.30) .41337
 H 1.00 (.77–1.30) .97143 1.00 (.78–1.29) .9710 .78 (.46–1.33) .3614 .97 (.82–1.13) .6678 1.04 (.87–1.25) .64907

Note.— The best results are shaded. An absence of values indicates a monomorphic SNP.

The remaining quantitative metabolic traits were studied only in nondiabetic controls, and sample sizes for these additional studies were significantly smaller than for diabetes or BMI (tables 6, 7, and 8). No significant associations were identified using unadjusted models for insulin resistance (HOMA-IR), insulin secretion (insulinogenic index), cholesterol levels, and systolic and diastolic blood pressure (table 6) or after adjustment for sex, age, and BMI (tables 7 and 8).

We specifically examined the results for the three missense variants that were hypothesized to have been adaptive in cold climates and to be related to “energy deficiency” diseases today.18,19 No association with increased risk of diabetes, obesity, or other metabolic traits was observed (table 11). The putative association of mt16189C with type 2 diabetes reported elsewhere2426 was not replicated here (n=6,608; odds ratio [OR] 1.03; 95% CI 0.88–1.21; Pnom=.36), which is consistent with other recent reports that did not support this hypothesis.27,28 With this sample size (under the assumption of an OR of 1.5 and an mt16189C allele frequency of 14%, consistent with previous reports), we have >99% power to reject the null hypothesis (of no association) at the P<.01 level.56

Table 11. .

Results of Association Testing of Three European mtDNA Variants Predicted to Be Selected for Adaptation to Cold Climates

mt4917G(ND2 N150D)
mt14798C(cytB F18L)
mt15257A(cytB D171N)
Phenotypea n Effect Estimateb Pnom Effect Estimateb Pnom Effect Estimateb Pnom
DM 6,608 .89 (.76–1.05) .16 .93 (.81–1.07) .30 .87 (.61–1.23) .47
BMI 6,523 −.002 .56 −.002 .59 .006 .39
Ins index 342 .04 .29 .05 .37 .31 .13
HOMA-IR 399 −.03 .59 .04 .27 .09 .55
Cholesterol 1,274 .13 .29 .03 .81 −.45 .05
Systolic BP 2,047 −.49 .76 1.13 .47 .39 .90
Diastolic BP 2,047 −.07 .92 .59 .43 −1.94 .21
a

BP = blood pressure; DM = diabetes mellitus, type 2; Ins = insulinogenic.

b

OR (95% CI) for DM and β for all other phenotypes.

Discussion

We set out to develop a comprehensive approach to mtDNA association testing that (a) captures all common coding-region mtDNA variants and haplogroups efficiently by use of linkage disequilibrium, (b) tests all common variants for association, and (c) accounts for the multiple comparisons implicit in testing the many variants in mtDNA. Compared with the methods in the literature, this approach provides a more complete and statistically conservative assessment of the role of common mtDNA variants in disease; the current application to diabetes and BMI provides a sample size threefold larger than any previous study.

Despite this well-powered evaluation, our analyses do not support the hypothesis that common mtDNA variants play a role in type 2 diabetes and BMI, at least in the European samples studied. The results from our association tests of all common mtDNA variants and the risk of type 2 diabetes show that there is no single common coding-region mtDNA variant in European populations that strongly influences risk of type 2 diabetes or BMI, which is consistent with recent results obtained by Mohlke et al.27 Haplogroup association results for type 2 diabetes were also consistent with noise. There may be population-specific variants that confer altered risk of diabetes (as in the Polish sample tested here), and further studies, including replication and complete resequencing,57 will be needed to explore that hypothesis. Our results showed no significant association of mtDNA variants with other metabolic traits (blood pressure, cholesterol, insulin secretion, and insulin resistance traits); however, this study was not as well powered for these traits.

It is interesting and perhaps surprising that we could not detect any phenotypic consequence of missense variants that were predicted to have been selected for in colder climates.2,19,58 Although our study does not directly address the hypothesis that climatic influences have led to selective adaptation of mtDNA variants, if common mtDNA variation does influence such traits, it is not reflected in glucose-stimulated insulin secretion, insulin resistance, body weight, blood pressure, cholesterol level, or type 2 diabetes.

This study does not address the role of mtDNA heteroplasmy in diabetes. Acquired somatic mtDNA mutations in tissues of relevance to type 2 diabetes are undetected in the blood samples used here. Typically, blood DNA exhibits much less heteroplasmy than nondividing tissues.59 In the 6,608 DNA samples tested, a very small amount of heteroplasmy was observed (1.1% of samples had one or more “heterozygous” calls), although the mass spectroscopy–based genotyping platform is sensitive to low-frequency spectral peaks corresponding to the alternate allele. Rare mitochondrial diseases exhibit more pronounced heteroplasmy, perhaps because cells with mutant alleles are inviable without wild-type mtDNA molecules. Thus, we think it is unlikely that mtDNA heteroplasmy for inherited variants significantly influenced our results.

These results should not be taken as addressing the broader hypothesis that mitochondrial OXPHOS plays a causal role in type 2 diabetes; there are >70 nuclear-encoded OXPHOS subunits and an estimated 1,500 mitochondrial proteins that are as yet untested. Moreover, although the mtDNA variants tested here do not appear to influence metabolic disease, inherited variation in mtDNA may influence risk of other diseases, such as Alzheimer disease, Parkinson disease, cardiovascular disease, cardiomyopathy, HIV lipodystrophy, and prostate cancer. A systematic evaluation of mtDNA and nuclear mitochondrial genes for a causal role in these diseases and an investigation of epistatic interactions between the two genomes will reveal the extent to which mitochondrial defects play a causal role in human disease.

Acknowledgments

D.A. is a Charles E. Culpeper Scholar of the Rockefeller Brothers Fund and a Burroughs Wellcome Fund Clinical Scholar in Translational Research. R.S. is a recipient of a National Institutes of Health National Research Service Award fellowship. This work was funded by a grant from the National Institute of Diabetes & Digestive & Kidney Diseases (to D.A.; Diabetes Genome Anatomy Project). D.A., J.N.H., M.J.D., and V.M. are recipients of The Richard and Susan Smith Family Foundation/American Diabetes Association Pinnacle Program Project Award. We thank M. Sun, for assistance with genotyping; colleagues at Massachussetts General Hospital, the Broad Institute, and investigators from Diabetes Genome Anatomy Project, for useful discussions; Mitokor, for 536 publicly available mtDNA sequences; MITOMAP, for being a resource for information about mtDNA polymorphisms; and submitters of mtDNA sequences to GenBank.

Web Resources

The URLs for data presented herein are as follows:

  1. Broad Institute Tagger: SNPs in human mtDNA, http://www.broad.mit.edu/mpg/tagger/mito.html (for information on sequence alignments, tSNP assays, and assay conditions)
  2. Human Mitochondrial DNA Revised Cambridge Reference Sequence, http://www.mitomap.org/mitoseq.html
  3. MITOMAP, http://www.mitomap.org/ (for information on mtDNA)
  4. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for Leigh syndrome; cardioencephalomyopathy; MELAS; KSS; MIDD; hypertension, hypercholesterolemia, and hypomagnesemia; type 2 diabetes; and Alzheimer, Parkinson, and Huntington diseases)

References

  • 1.Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, Patterson N, Lander ES, Mann M (2003) Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115:629–640 10.1016/S0092-8674(03)00926-7 [DOI] [PubMed] [Google Scholar]
  • 2.Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407 10.1146/annurev.genet.39.110304.095751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dimauro S, Davidzon G (2005) Mitochondrial DNA and disease. Ann Med 37:222–232 10.1080/07853890510007368 [DOI] [PubMed] [Google Scholar]
  • 4.Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9–13 10.1016/j.cmet.2005.12.001 [DOI] [PubMed] [Google Scholar]
  • 5.Zeviani M, Di Donato S (2004) Mitochondrial disorders. Brain 127:2153–2172 10.1093/brain/awh259 [DOI] [PubMed] [Google Scholar]
  • 6.Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389–402 10.1038/nrg1606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Barrett TG (2001) Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. Best Pract Res Clin Endocrinol Metab 15:325–343 10.1053/beem.2001.0149 [DOI] [PubMed] [Google Scholar]
  • 8.van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA (1992) Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368–371 10.1038/ng0892-368 [DOI] [PubMed] [Google Scholar]
  • 9.Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306:1190–1194 10.1126/science.1102521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171 [DOI] [PubMed] [Google Scholar]
  • 11.Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950 [DOI] [PubMed] [Google Scholar]
  • 12.Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54:8–14 [DOI] [PubMed] [Google Scholar]
  • 13.Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273 10.1038/ng1180 [DOI] [PubMed] [Google Scholar]
  • 14.Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471 10.1073/pnas.1032913100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142 10.1126/science.1082889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671 10.1056/NEJMoa031314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Petersen KF, Dufour S, Shulman GI (2005) Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2:e233 10.1371/journal.pmed.0020233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark AG, Hosseini S, Brandon M, Easley K, Chen E, Brown MD, Sukernik RI, Olckers A, Wallace DC (2003) Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci USA 100:171–176 10.1073/pnas.0136972100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC, Coskun PE, Golik P, Macaulay V, Clark AG, Hosseini S, Easley K, Chen E, Brown MD, Sukernik RI, Olckers A (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303:223–226 10.1126/science.1088434 [DOI] [PubMed] [Google Scholar]
  • 20.Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384–387 10.1126/science.1104343 [DOI] [PubMed] [Google Scholar]
  • 21.Savage DB, Petersen KF, Shulman GI (2005) Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45:828–833 10.1161/01.HYP.0000163475.04421.e4 [DOI] [PubMed] [Google Scholar]
  • 22.Schapira AH (1999) Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia. Biochim Biophys Acta 1410:159–170 10.1016/S0005-2728(98)00164-9 [DOI] [PubMed] [Google Scholar]
  • 23.Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495–505 10.1002/ana.20624 [DOI] [PubMed] [Google Scholar]
  • 24.Poulton J, Brown MS, Cooper A, Marchington DR, Phillips DI (1998) A common mitochondrial DNA variant is associated with insulin resistance in adult life. Diabetologia 41:54–58 10.1007/s001250050866 [DOI] [PubMed] [Google Scholar]
  • 25.Poulton J, Bednarz AL, Scott-Brown M, Thompson C, Macaulay VA, Simmons D (2002) The presence of a common mitochondrial DNA variant is associated with fasting insulin levels in Europeans in Auckland. Diabet Med 19:969–971 10.1046/j.0742-3071.2002.00836.x [DOI] [PubMed] [Google Scholar]
  • 26.Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ (2002) Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 11:1581–1583 10.1093/hmg/11.13.1581 [DOI] [PubMed] [Google Scholar]
  • 27.Mohlke KL, Jackson AU, Scott LJ, Peck EC, Suh YD, Chines PS, Watanabe RM, Buchanan TA, Conneely KN, Erdos MR, Narisu N, Enloe S, Valle TT, Tuomilehto J, Bergman RN, Boehnke M, Collins FS (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet 118:245–254 10.1007/s00439-005-0046-4 [DOI] [PubMed] [Google Scholar]
  • 28.Chinnery PF, Elliott HR, Patel S, Lambert C, Keers SM, Durham SE, McCarthy MI, Hitman GA, Hattersley AT, Walker M (2005) Role of the mitochondrial DNA 16184–16193 poly-C tract in type 2 diabetes. Lancet 366:1650–1651 10.1016/S0140-6736(05)67492-2 [DOI] [PubMed] [Google Scholar]
  • 29.Herrnstadt C, Howell N (2004) An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders. Mitochondrion 4:791–798 10.1016/j.mito.2004.07.041 [DOI] [PubMed] [Google Scholar]
  • 30.Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N (2002) Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70:1152–1171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Florez JC, Sjogren M, Burtt N, Orho-Melander M, Schayer S, Sun M, Almgren P, Lindblad U, Tuomi T, Gaudet D, Hudson TJ, Daly MJ, Ardlie KG, Hirschhorn JN, Altshuler D, Groop L (2004) Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes 53:3313–3318 [DOI] [PubMed] [Google Scholar]
  • 32.Winckler W, Graham RR, de Bakker PI, Sun M, Almgren P, Tuomi T, Gaudet D, Hudson TJ, Ardlie KG, Daly MJ, Hirschhorn JN, Groop L, Altshuler D (2005) Association testing of variants in the hepatocyte nuclear factor 4α gene with risk of type 2 diabetes in 7,883 people. Diabetes 54:886–892 [DOI] [PubMed] [Google Scholar]
  • 33.Tang K, Oeth P, Kammerer S, Denissenko MF, Ekblom J, Jurinke C, van den Boom D, Braun A, Cantor CR (2004) Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry. J Proteome Res 3:218–227 10.1021/pr034080s [DOI] [PubMed] [Google Scholar]
  • 34.Autere J, Moilanen JS, Finnila S, Soininen H, Mannermaa A, Hartikainen P, Hallikainen M, Majamaa K (2004) Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia. Hum Genet 115:29–35 10.1007/s00439-004-1123-9 [DOI] [PubMed] [Google Scholar]
  • 35.Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, Feraco E, Andreev KF, Yashin AI, Franceschi C, De Benedictis G (2001) Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer’s disease. Hum Genet 108:194–198 10.1007/s004390100463 [DOI] [PubMed] [Google Scholar]
  • 36.Dato S, Passarino G, Rose G, Altomare K, Bellizzi D, Mari V, Feraco E, Franceschi C, De Benedictis G (2004) Association of the mitochondrial DNA haplogroup J with longevity is population specific. Eur J Hum Genet 12:1080–1082 10.1038/sj.ejhg.5201278 [DOI] [PubMed] [Google Scholar]
  • 37.De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 13:1532–1536 [DOI] [PubMed] [Google Scholar]
  • 38.De Benedictis G, Carrieri G, Varcasia O, Bonafe M, Franceschi C (2000) Inherited variability of the mitochondrial genome and successful aging in humans. Ann N Y Acad Sci 908:208–218 [DOI] [PubMed] [Google Scholar]
  • 39.Giacchetti M, Monticelli A, De Biase I, Pianese L, Turano M, Filla A, De Michele G, Cocozza S (2004) Mitochondrial DNA haplogroups influence the Friedreich’s ataxia phenotype. J Med Genet 41:293–295 10.1136/jmg.2003.015289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Khogali SS, Mayosi BM, Beattie JM, McKenna WJ, Watkins H, Poulton J (2001) A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 357:1265–1267 10.1016/S0140-6736(00)04422-6 [DOI] [PubMed] [Google Scholar]
  • 41.Momiyama Y, Furutani M, Suzuki Y, Ohmori R, Imamura S, Mokubo A, Asahina T, Murata C, Kato K, Anazawa S, Hosokawa K, Atsumi Y, Matsuoka K, Kimura M, Kasanuki H, Ohsuzu F, Matsuoka R (2003) A mitochondrial DNA variant associated with left ventricular hypertrophy in diabetes. Biochem Biophys Res Commun 312:858–864 10.1016/j.bbrc.2003.10.195 [DOI] [PubMed] [Google Scholar]
  • 42.Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, Majamaa K (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 112:29–33 10.1007/s00439-002-0843-y [DOI] [PubMed] [Google Scholar]
  • 43.Niemi AK, Moilanen JS, Tanaka M, Hervonen A, Hurme M, Lehtimaki T, Arai Y, Hirose N, Majamaa K (2005) A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13:166–170 10.1038/sj.ejhg.5201308 [DOI] [PubMed] [Google Scholar]
  • 44.Ross OA, McCormack R, Curran MD, Duguid RA, Barnett YA, Rea IM, Middleton D (2001) Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp Gerontol 36:1161–1178 10.1016/S0531-5565(01)00094-8 [DOI] [PubMed] [Google Scholar]
  • 45.Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K (1998) Mitochondrial genotype associated with longevity. Lancet 351:185–186 10.1016/S0140-6736(05)78211-8 [DOI] [PubMed] [Google Scholar]
  • 46.Tanaka M (2002) Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson’s disease. J Neurol Suppl 2 249:II/11–II/18 [DOI] [PubMed] [Google Scholar]
  • 47.van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, et al (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72:804–811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365:28–32 10.1016/j.neulet.2004.04.051 [DOI] [PubMed] [Google Scholar]
  • 49.Huerta C, Castro MG, Coto E, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Martinez C, Lahoz CH, Alvarez V (2005) Mitochondrial DNA polymorphisms and risk of Parkinson’s disease in Spanish population. J Neurol Sci 236:49–54 10.1016/j.jns.2005.04.016 [DOI] [PubMed] [Google Scholar]
  • 50.Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus ML, Wallace DC (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144:1835–1850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kruglyak L, Nickerson DA (2001) Variation is the spice of life. Nat Genet 27:234–236 10.1038/85776 [DOI] [PubMed] [Google Scholar]
  • 52.Reich DE, Gabriel SB, Altshuler D (2003) Quality and completeness of SNP databases. Nat Genet 33:457–458 10.1038/ng1133 [DOI] [PubMed] [Google Scholar]
  • 53.The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320 10.1038/nature04226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D (2005) Efficiency and power in genetic association studies. Nat Genet 37:1217–1223 10.1038/ng1669 [DOI] [PubMed] [Google Scholar]
  • 55.Marchini J, Donnelly P, Cardon LR (2005) Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 37:413–417 10.1038/ng1537 [DOI] [PubMed] [Google Scholar]
  • 56.Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150 10.1093/bioinformatics/19.1.149 [DOI] [PubMed] [Google Scholar]
  • 57.Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Chakravarti A (2004) The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 14:812–819 10.1101/gr.2228504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kivisild T, Shen P, Wall DP, Do B, Sung R, Davis KK, Passarino G, Underhill PA, Scharfe C, Torroni A, Scozzari R, Modiano D, Coppa A, de Knijff P, Feldman MW, Cavalli-Sforza LL, Oefner PJ (2006) The role of selection in the evolution of human mitochondrial genomes. Genetics 172:373–387 10.1534/genetics.105.043901 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U (1996) Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci USA 93:12382–12387 10.1073/pnas.93.22.12382 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES